DEVELOPMENT OF BIOMATERIALS FOR CALVARIAL BONE REGENERATION AND APPLICATION TO TRAUMATIC BRAIN INJURY by Townsend, Jakob
 
 
UNIVERSITY OF OKLAHOMA 
GRADUATE COLLEGE 
 
 
 
 
DEVELOPMENT OF BIOMATERIALS FOR CALVARIAL BONE 
REGENERATION AND APPLICATION TO TRAUMATIC BRAIN INJURY 
 
 
 
A DISSERTATION  
SUBMITTED TO THE GRADUATE FACULTY 
In partial fulfillment of the requirements for the  
Degree of  
DOCTOR OF PHILOSOPHY 
 
 
By 
 
JAKOB M. TOWNSEND 
Norman, Oklahoma 
2017 
 
 
 
 
 
 
 
DEVELOPMENT OF BIOMATERIALS FOR CALVARIAL BONE 
REGENERATION AND APPLICATION TO TRAUMATIC BRAIN INJURY 
 
 
A DISSERTATION APPROVED FOR THE  
STEPHENSON SCHOOL OF BIOMEDICAL ENGINEERING 
 
 
 
 
 
 
 
 
 
 
BY 
 
 
 
 
         
Dr. Michael Detamore, Chair 
 
 
 
           
Dr. Barbara Safiejko-Mroczka 
 
 
 
           
Dr. Vassilios Sikavitsas 
 
 
 
           
Dr. Lei Ding 
 
 
 
        
Dr. Bradley Bohnstedt 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by JAKOB M. TOWNSEND 2017 
All Rights Reserved. 
 
 
iv 
 
Acknowledgments 
 What a crazy ride it has been. I never could have imagined the amount of 
personal and professional growth I would experience during my graduate studies. 
I am forever indebted to my graduate mentors, friends, and family members that 
have supported my dream of achieving my doctorate. What was once an 
unobtainable goal is now within reach, I am truly a lucky person to have fallen in 
the presence of such amazing individuals. I never could have achieved my 
current academic accomplishments if it was not for the support of those around 
me. I would like to thank those people: 
 I would first like to thank my advisor, Dr. Michael Detamore, for his 
constant support, guidance, and encouragement during my graduate studies. His 
advice in both professional and personal matters has helped to shape my life for 
the better. Michael has pushed me to achieve my goals and I couldn’t have asked 
for a better advisor. I am proud to call him both my mentor and friend.  
 I would like to thank my committee members, Dr. Barbara Safiejko-
Mroczka, Dr. Vassilios Sikavitsas, Dr. Lei Ding, and Dr. Bradley Bohnstedt for 
their guidance and support in my graduate studies. The individual perspectives 
of each committee member have helped to build my graduate work immensely. I 
would also like to thank my past co-advisor at the University of Kansas, Dr. Cory 
Berkland, for his continuous support during my time at the University of Kansas 
and after the move to the University of Oklahoma. I would also like to thank the 
co-authors who have contributed to the body of work presented: Brian Andrews, 
Connor Dennis, Erik Van Kampen, Jinxi Wang, Jon Whitlow, Randolph Nudo, 
 
 
v 
 
Stevin Gehrke, Taylor Zabel, and Yi Feng. I would also like to thank previous and 
current collaborators who helped process samples: Hong Liu, Di Wu, and Kar-
Ming Fung. Research reported in the dissertation was supported by the National 
Institute of Dental and Craniofacial Research of the National Institutes of Health 
under Award Number R01 DE022472 and R03 DE025906. The content is solely 
the responsibility of the author and does not necessarily represent the official 
views of the National Institutes of Health. 
 I would like to thank Peggy and Charles Stephenson for their exceptional 
generosity and support in starting the Stephenson School of Biomedical 
Engineering. Peggy and Charles generously provided a graduate fellowship 
which allowed myself to pursue research full-time and I am very grateful to their 
kindness.  
 I would like to thank the undergraduate researchers who have helped in 
completing the research presented in the current dissertation. I would like to 
personally thank Taylor Zabel for his hard work in mechanically characterizing 
hydrogels, and Mike Holtz for hard work in helping to produce materials used 
throughout the PhD. I would also like to thank Nina Cassidy for help in designing 
the next-generation of biomaterials past the current dissertation. The research 
was truly elevated by the hard work put forth by these undergraduates and I only 
see success in their futures.  
 I would like to thank the current and past members of the Detamore Lab; 
Lindsey Ott, BanuPriya Sridharan, Vineet Gupta, Cate Wisdom, A.J. Mellott, 
Stefan Lohfeld, and Salma Mahzoon who have helped guide the beginning of my 
 
 
vi 
 
scientific career in regenerative medicine. I would like to thank Peggy Keefe for 
the countless baked goods, support, and advice given throughout my graduate 
studies. I would like to thank Jeannie Salash and Emi Kiyotake for being amazing 
both scientifically and as human beings. I would like to thank Emily Beck for being 
a wonderful lab-mate, mentor, friend, and sushi buddy. I would like to thank the 
countless friends I have made during my graduate studies for the constant sanity 
checks and pressure to stop working and come out for a beer.  
 I would like to thank my friends at the Shenago Lounge; Chris Golden, 
Shara Thati, Darrell Goebel, and Brad Black for always cheering me up after the 
hard days, and for providing a part-time job to escape graduate school life. I would 
like to thank the new friends I have made at the climbing gym, I am so very happy 
to be surrounded by such supportive people. 
 I would like to thank my previous mentors at Oregon State University, 
Christine Kelly and Curtis Lajoie, for their mentorship in undergraduate research. 
I would never have known of graduate school as an option if it was not for 
Christine’s support, or believed I was smart enough to tackle such a challenge if 
it was not for Curtis’ encouragement. I will never forget the fond memories I have 
working in the Kelly lab. 
  I would like to thank members of the TrilliumFiber Fuels team, Joshua 
Kitner and Steve Potochnik, who mentored me during a year-long internship. I 
can attribute my basic lab and research skills to the training I received from my 
time working with these two individuals.  
 
 
vii 
 
 Lastly, I would like to thank my family. To my parents, Tammy and Michael, 
I would not be the person I am today if it was not for your constant love, support, 
and advice. Mom, thank you for going the extra mile to teach me basic math, I 
will never forget how much I loathed those summer math problems as a kid. Dad, 
thank you for providing the option to pursue any path in life. To my grandparents, 
thank you for always supporting my fascination for discovery. I do apologize for 
taking apart your electronics in an attempt to figure out how they worked. To my 
sister Erika, thank you for always being there when I needed you the most. 
  
 
 
viii 
 
Table of Contents 
Acknowledgments ..............................................................................................iv 
Table of Contents ............................................................................................. viii 
List of Figures .................................................................................................... xii 
List of Tables .................................................................................................... xiii 
Abstract ............................................................................................................ xiv 
Chapter 1: Introduction ....................................................................................... 1 
Chapter 2: Flow Behavior Prior to Crosslinking: The Need for Precursor 
Rheology for Placement of Hydrogels in Medical Applications1 ......................... 7 
Abstract ........................................................................................................... 7 
Introduction ..................................................................................................... 8 
Biomedical Hydrogel Perspective ................................................................. 12 
Our Inspiration ........................................................................................... 12 
Translation of Technology to Surgeons ..................................................... 14 
Biomedical Hydrogel Perspective Summary ............................................. 15 
Surgical Context ........................................................................................... 16 
Injectability/Syringeability and Shear Properties ....................................... 16 
Placement and Recovery Time ................................................................. 18 
Retention and Yield Stress ........................................................................ 19 
Rheological Methods ................................................................................. 22 
Surgical Context Summary ........................................................................ 23 
Hydrogel Rheology Properties ...................................................................... 24 
Paste and Putty Nomenclature .................................................................. 24 
Paste and Putty Application ...................................................................... 26 
Herschel-Bulkley Model ............................................................................. 26 
Summary ................................................................................................... 28 
Hydrogel Precursor Considerations .............................................................. 28 
Chemically Crosslinked Hydrogels ............................................................ 28 
Physically Crosslinked Hydrogels ............................................................. 31 
Combinational Crosslinking Hydrogels ...................................................... 32 
Crosslinking Hydrogels Summary ............................................................. 33 
Conclusions .................................................................................................. 33 
 
 
ix 
 
Chapter 3: Colloidal Gels with Extracellular Matrix Particles and Growth Factors 
for Bone Regeneration in Critical Size Rat Calvarial Defects2 .......................... 35 
Abstract ......................................................................................................... 35 
Introduction ................................................................................................... 36 
Materials and Methods.................................................................................. 41 
Materials .................................................................................................... 41 
Preparation of Decellularized Cartilage (DCC) .......................................... 41 
Preparation of Colloidal Gels ..................................................................... 42 
Environmental Scanning Electron Microscopy (ESEM) ............................. 43 
Rheological Testing ................................................................................... 43 
Animal Model and Surgical Method ........................................................... 44 
Micro-computed Tomography (μCT) ......................................................... 44 
Histology and Immunohistochemistry ........................................................ 45 
Statistical Methods .................................................................................... 46 
Results .......................................................................................................... 47 
Rheological Analysis ................................................................................. 47 
Microcomputed Tomography (μCT) Analysis ............................................ 47 
Histological Analysis.................................................................................. 48 
Immunohistochemical (IHC) Analysis ........................................................ 48 
Discussion .................................................................................................... 49 
Conclusion .................................................................................................... 53 
Chapter 4: Decellularized Cartilage-Based Hydrogel Encapsulating 
Osteoconductive Particles for Calvarial Bone Regeneration3 ........................... 55 
Abstract ......................................................................................................... 55 
Introduction ................................................................................................... 56 
Materials and Methods.................................................................................. 60 
Preparation of Decellularized Cartilage (DCC) .......................................... 60 
Synthesis of Methacrylated Solubilized Decellularized Cartilage (MeSDCC)
 .................................................................................................................. 61 
Rat Bone Marrow Harvest and Culture ...................................................... 62 
Hydrogel Preparation ................................................................................ 63 
Rheological Testing of Hydrogel Precursor Solution ................................. 64 
Mechanical Testing of Crosslinked Hydrogel ............................................ 65 
 
 
x 
 
Animal Model and Surgical Method ........................................................... 66 
Micro-computed Tomography (µCT) ......................................................... 66 
Histology and Immunohistochemistry (IHC) .............................................. 67 
Statistical Methods .................................................................................... 69 
Results .......................................................................................................... 69 
Rheological Analysis of Hydrogel Precursor ............................................. 69 
Mechanical Analysis of Crosslinked Hydrogel ........................................... 69 
Micro-computed Tomography (µCT) Analysis ........................................... 70 
Histological and Immunohistochemistry (IHC) Analysis ............................ 70 
Discussion .................................................................................................... 71 
Conclusion .................................................................................................... 76 
Chapter 5: Superior Calvarial Bone Regeneration with Pentenoate-
Functionalized Hyaluronic Acid Hydrogels with Devitalized Tendon Particles4 78 
Abstract ......................................................................................................... 78 
Introduction ................................................................................................... 79 
Materials and Methods.................................................................................. 82 
Preparation of Devitalized Tissue .............................................................. 82 
Synthesis of Pentenoate Functionalized Hyaluronic Acid (PHA) ............... 83 
Hydrogel Preparation ................................................................................ 83 
Rheological Testing of Hydrogel Precursor ............................................... 84 
Mechanical Testing of Crosslinked Hydrogel ............................................ 84 
Animal Model and Surgical Method ........................................................... 85 
Micro-Computed Tomography (µCT) ........................................................ 86 
Histology and Immunohistochemistry (IHC) .............................................. 86 
In Vitro Cell Culture and Experimental Design .......................................... 87 
Biochemical Assays .................................................................................. 88 
Statistical Methods .................................................................................... 88 
Results .......................................................................................................... 89 
Rheological Analysis of Hydrogel Precursor ............................................. 89 
Mechanical Analysis of Crosslinked Hydrogel ........................................... 90 
Micro-computed Tomography (µCT) Analysis ........................................... 90 
Histological Analysis.................................................................................. 91 
Biochemical Analysis from In Vitro Study .................................................. 92 
 
 
xi 
 
Discussion .................................................................................................... 93 
Conclusion .................................................................................................... 97 
Chapter 6: Conclusion ...................................................................................... 99 
References ..................................................................................................... 106 
Appendix A: Figures ....................................................................................... 127 
Appendix B: Tables ........................................................................................ 148 
 
 
 
 
 
xii 
 
List of Figures 
Chapter 1 
Figure 1.1: Illustration of Dissertation Aims .................................................... 128 
Figure 1.2: Illustration of Implanted Hydrogel Pliability ................................... 129 
 
Chapter 2 
Figure 2.1: Liquid, paste, and Putty Precursor Solutions ................................ 130 
Figure 2.2: Illustration of Real and Induced Defects ....................................... 131 
Figure 2.3. Defect Retention of Liquid Compared to Paste or Putty ............... 132 
Figure 2.4: Methods to Determine Yield Stress .............................................. 133 
 
Chapter 3 
Figure 3.1: Surgical Method and Material ESEM Images ............................... 134 
Figure 3.2: Aim 1 Hydrogel Precursor Yield Stress ........................................ 135 
Figure 3.3: Aim 1 Regenerated Bone Volume and CT Imaging ................... 136 
Figure 3.4: Aim 1 H&E Staining ...................................................................... 137 
Figure 3.5: Aim 1 Immunohistochemistry ....................................................... 138 
 
Chapter 4 
Figure 4.1: Aim 2 Hydrogel Precursor Yield Stress ........................................ 139 
Figure 4.2: Aim 2 Hydrogel Compressive Modulus ........................................ 140 
Figure 4.3: Aim 2 Regenerated Bone Volume and CT Imaging ................... 141 
Figure 4.4: Aim 2 H&E Staining ...................................................................... 142 
Figure 4.5: Aim 2 Immunohistochemistry ....................................................... 143 
 
Chapter 5 
Figure 5.1: Aim 3 Mechanical Characterization .............................................. 144 
Figure 5.2: Aim 3 Regenerated Bone Volume and µCT Imaging ................... 145 
Figure 5.3: Aim 3 H&E Staining ...................................................................... 146 
Figure 5.4: Aim 3 Biochemical Analysis ......................................................... 147 
  
 
 
xiii 
 
List of Tables 
Chapter 1 
No Tables 
 
Chapter 2 
Table 2.1: Summary of Hydrogel Rheological Properties ............................... 149 
 
Chapter 3 
No Tables 
 
Chapter 4 
No Tables 
 
Chapter 5 
No Tables 
 
Chapter 6 
No Tables 
  
 
 
xiv 
 
Abstract 
 In the treatment of severe traumatic brain injury (TBI), a two-stage surgical 
intervention is routinely performed. In the first surgery, decompressive 
craniectomy (DC) is performed to remove a large portion of calvarial bone to allow 
unimpeded brain swelling. A second surgery termed cranioplasty, usually 
performed weeks to months later, is then employed to rebuild the cranium. 
Hydrogels have the potential to revolutionize TBI treatment by permitting a single-
stage surgical intervention, capable of exhibiting paste-like handling properties in 
the pre-crosslinked form for in situ placement to fill any size or shape of defect, 
remaining pliable during brain swelling, and tuned to regenerate bone after 
swelling has subsided. The motive of the current dissertation was to achieve the 
first step in designing a single-stage surgical intervention for treatment of TBI 
following DC, being the design of a hydrogel capable of regenerating bone within 
a critical size calvarial defect. The current dissertation first evaluated the use of 
colloidal hydrogels of hyaluronic acid, hydroxyapatite, and extracellular matrix 
(ECM) materials demonstrating promise for decellularized cartilage as a material 
for bone regenerative medicine. A next-generation biomaterial was then 
developed utilizing a methacrylated solubilized decellularized cartilage hydrogel 
encapsulating osteoconductive particles, the results of which demonstrated 
diminished bone regeneration that was speculated to be due to cartilage 
processing (i.e., solubilization). In the final study, pentenoate-functionalized 
hyaluronic acid (PHA) hydrogels encapsulating devitalized ECM materials were 
evaluated and I found that PHA hydrogels encapsulating devitalized tendon 
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(DVT) particles successfully regenerated bone in a critical size calvarial defect. 
Future studies will be conducted to test the use of the PHA-DVT hydrogel in a rat 
TBI model to evaluate the use of hydrogels in the treatment of TBI following DC. 
Ultimately, the current dissertation work successfully developed a hydrogel 
material that exhibits desirable handling properties in the pre-crosslinked form for 
surgical placement and adequate bone regeneration after 8 weeks of in vivo 
implantation, with promising future applications to bone regeneration and 
application to treatment of TBI.   
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Chapter 1: Introduction 
 The long-term goal of the dissertation was the creation of a material to aid 
in the treatment of traumatic brain injury (TBI). TBI is a life-threatening condition 
diagnosed by internal brain herniation. Severe TBI is commonly treated by a two-
stage surgical procedure. In the first surgery, a decompressive craniectomy (DC) 
procedure is conducted to remove a large portion of calvarial bone to allow un-
impeded brain swelling beyond the cranial confines. Weeks to months later, a 
second surgery termed cranioplasty is performed to restore the cranial vault. The 
current two-stage surgical intervention has disadvantages as it prolongs 
neurorehabilitation and recovery, increases medical costs, and is associated with 
causing the neurological condition termed syndrome of the trephined (SoT). SoT, 
also known as sinking skin flap syndrome, is a neurological condition associated 
with symptoms such as mood changes, fatigue, headaches, dizziness, fine motor 
dexterity issues, and difficulties concentrating. SoT is thought to be caused by 
changing intracranial pressure or deformation of the brain from the overlying 
scalp after the DC procedure. TBI treatment would greatly benefit from a single-
stage surgery using a material that could be implanted in the initial surgery, 
remain pliable enough to allow brain swelling, then transition to bone after 
swelling has subsided.  
 Hydrogels were identified as an attractive material option for application to 
a single-stage surgical model for TBI treatment. Hydrogels offer the ability for in 
situ placement to fill irregularly shaped defects, crosslinking for material retention 
at the injury site, a tunable degree of pliability, and selective material properties 
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for osteogenic promotion (Fig. 1.2). Additionally, hydrogel precursor solutions that 
exhibit paste or putty-like handling properties would allow for ease of placement 
and retention into the defect site. With these design parameters in mind, the 
following specific aims were designed: (1) assessment of physically crosslinked 
hydrogels composed of extracellular matrix materials (ECM) and growth factors, 
(2) evaluation of naturally derived crosslinking hydrogels encapsulating synthetic 
colloids, and (3) evaluation of synthetic crosslinking hydrogels encapsulating 
ECM colloidal particles (Fig. 1.1).  
 Aim 1 attempted to utilize a simple non-crosslinking hydrogel design to 
evaluate the use of hyaluronic acid (HA), synthetic hydroxyapatite, and natural 
ECM materials of demineralized bone matrix (DBM) or decellularized cartilage 
(DCC) with or without growth factors to generate new bone formation. The 
second aim attempted to address the observed issues of aim 1 regarding material 
retention issues while expanding on the use of DCC as a material for calvarial 
bone regeneration. Aim 2 utilized a solubilized and methacrylated DCC 
(MeSDCC) hydrogel encapsulating synthetic colloids. The third aim attempted to 
combine the positive aspects of aim 1 and aim 2, the bone regenerative potential 
and photocrosslinking, respectively. Aim 3 utilized a pentanoate-functionalized 
hyaluronic acid (PHA) hydrogel and devitalized tissue particles of bone, cartilage, 
meniscus, and tendon for evaluation in calvarial bone regeneration. All work 
presented in the following chapters was a product of my own effort with the 
exception of the animal surgeries that were conducted by Dr. Yi Feng and Dr. 
Jinxi Wang at the University of Kansas Medical Center and the histology 
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sectioning/staining presented in Aim 3 that was conducted by the Stephenson 
Cancer Tissue Pathology Core at the University of Oklahoma Health Sciences 
Center. Individual chapters communicate work that is in preparation, submitted, 
or published as indicted by the footnote at the bottom of each associated chapter. 
The following chapters represent the chronological organization of the 
aforementioned aims: 
 Chapter 2 is a review that provides informative advice to the hydrogel field 
on rheology and how better evaluation of hydrogel precursor solutions (i.e., 
hydrogels solutions before crosslinking) can lead to easier clinical adoption. The 
final hurdle in translating a new treatment from the lab bench to the clinic is 
clinician adoption and use. A new and potentially impactful technology can be 
overlooked if the associated learning curve is too difficult. Here I propose yield 
stress (i.e., the stress required for a material to begin to flow) ranges for liquid 
(no yield stress), paste (100-2000 Pa), and putty (2000+ Pa) handling properties. 
By designing materials with similar handling properties to currently available 
materials the surgeon technology learning curve can be minimized to ease 
clinician adoption. 
 Chapter 3 addresses the first aim, using a non-crosslinking hydrogel 
comprised of HA, hydroxyapatite nanoparticles (HAp), and ECM materials of 
DBM or DCC to evaluate bone regeneration in an in vivo rat critical-size calvarial 
defect model. The HA-HAp-ECM hydrogels were evaluated for their yield stress, 
regenerated bone volume by micro-computed tomography (CT), histology, and 
immunohistochemistry to compare osteogenic potential in vivo. Encouraging 
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results illustrating comparable bone regeneration between growth factor and 
DCC-containing materials prompted further research into using a 
photocrosslinkable cartilage hydrogel in Aim 2. Aim 1 represents our first attempt 
at using non-traditional ECM materials (i.e., cartilage) to promote bone formation, 
the work presented heavily influenced the direction of the research and 
subsequent aims. The aim 1 study was the first to use naturally derived 
decellularized cartilage extracellular matrix for calvarial bone regeneration. 
 Chapter 4 addresses the second aim, using a methacrylated solubilized 
decellularized cartilage (MeSDCC) hydrogel encapsulating synthetic osteogenic 
particles of hydroxyapatite nanofibers (HAPnf), bioglass microparticles (BG), or 
added rat bone marrow-derived mesenchymal stem cells (rMSCs) for bone 
regeneration in critical-size rat calvarial defects. Particles of HAPnf or BG were 
added for two specific reasons: 1) delivery of known osteoconductive materials 
to aid in bone regeneration, and 2) to create hydrogel precursor materials that 
exhibit paste-like handling properties for physical placement and shaping before 
crosslinking. Fibrin hydrogels were employed as a control material for the study. 
Hydrogels used in the study were evaluated for their yield stress before 
crosslinking, compressive modulus post-crosslinking, regenerated bone volume, 
histology, and immunohistochemistry to evaluate bone regeneration in a critical-
size rat calvarial defect. The use of the MeSDCC hydrogels was inspired by the 
results of Aim 1 suggesting that DCC particles could promote similar bone 
regeneration compared to growth factor containing groups. Minimal bone 
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regeneration using the MeSDCC hydrogels prompted the re-evaluation of 
crosslinking hydrogels.  
 Chapter 5 addresses the third aim, using a pentanoate-functionalized 
hyaluronic acid (PHA) hydrogel encapsulating ECM tissue particles of DBM, 
devitalized cartilage (DVC), devitalized meniscus (DVM), or devitalized tendon 
(DVT) for bone regeneration in critical-size rat calvarial defects. After discussions 
with surgeons, faster material crosslinking times were determined to be of great 
importance for successful clinical translation. Additionally, hyaluronic acid based 
colloidal gels used in the first aim demonstrated adequate bone regeneration. For 
these reasons, pentenoate-functionalized hyaluronic acid (PHA) hydrogels were 
determined to be an attractive material choice highlighting fast crosslinking times 
(1-2 minutes).  PHA-ECM hydrogels were evaluated for precursor yield stress, 
post-crosslinking compressive modulus, regenerated bone, and histology to 
evaluate new bone formation. Leading groups were further refined in vitro to 
determine the minimum ECM particle concentration required to achieve desirable 
bone formation. Aim 3 was designed in an attempt to combine the positive 
aspects of both aims 1 and 2 to develop a better material for calvarial bone 
regeneration. The materials from aim 1 and the crosslinking from aim 2 were 
combined to create the new crosslinking hydrogels encapsulating different ECM 
materials.  
 Chapter 6 serves as the conclusion to the dissertation and provides a 
summary of the most important findings, comparison between specific aims, and 
a global perspective of the dissertation work.  Recommendations are provided for 
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future work to design the next generation of materials for calvarial bone 
regeneration and application to TBI.  
 Overall, the work presented in the current dissertation provides the first 
step in the development of materials for application to TBI treatment after DC. 
The work has focused on developing cost-effective, highly translatable, acellular, 
pliable, and easy to use hydrogel treatments to achieve a single-stage surgical 
procedure for the treatment of TBI. Other treatment options such as DBX®, 
NovaBone Putty®, and custom-made implants generated from CT scans exist; 
however, these treatment options cannot be used in a single-stage surgical 
approach as they do not remain pliable and thus impede brain swelling. A 
secondary issue with currently available treatment options exists in that the 
materials themselves do not regenerate adequate bone in the critical size 
calvarial defect created during DC. Hydrogels are an attractive option as the 
materials are inherently pliable, and have demonstrated improved bone 
regeneration. Although the work in the current dissertation did not solve the entire 
issue associated with developing a treatment for TBI, it did provide the beginning 
foundation for a hydrogel material with potential for a single-stage surgical 
approach for the treatment of TBI.  
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Chapter 2: Flow Behavior Prior to Crosslinking: The Need for 
Precursor Rheology for Placement of Hydrogels in Medical 
Applications1 
 
Abstract 
Hydrogels – water swollen cross-linked networks – have demonstrated 
considerable promise in tissue engineering and regenerative medicine 
applications. However, ambiguity over which rheological properties are needed 
to characterize these gels before crosslinking still exists. Most hydrogel research 
focuses on the performance of the hydrogel construct after implantation, but for 
clinical practice, and for related applications such as bioinks for 3D bioprinting, 
the behavior of the pre-gelled state is also critical. Therefore, the goal of this 
review is to emphasize the need for more attention paid to the development and 
characterization of hydrogel precursor formulations with desirable rheological 
properties. In particular, we consider engineering paste or putty precursor 
solutions (i.e., suspensions with a yield stress), and distinguish between these 
differences to ease the path to clinical translation. The connection between 
rheology and surgical application as well as how the use of paste and putty 
nomenclature can help to qualitatively identify material properties are explained. 
Quantitative rheological properties for defining materials as either pastes or 
putties are proposed to enable easier adoption to current methods. Specifically, 
   
1Submitted as: Townsend JM, Beck EC, Gehrke SH, Berkland CJ, Detamore MS. Flow 
Behavior Prior to Crosslinking: The Need for Precursor Rheology for Placement of Hydrogels 
in Medical Applications. Progress in Polymer Science, 2017. 
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the three-parameter Herschel-Bulkley model is proposed as a suitable model to 
correlate experimental data and provide a basis for meaningful comparison 
between different materials. This model combines a yield stress, the critical 
parameter distinguishing solutions from pastes (100-2000 Pa) and from putties 
(>2000 Pa), with power law fluid behavior once the yield stress is exceeded. 
Overall, successful implementation of paste or putty handling properties to the 
hydrogel precursor may minimize the surgeon-technology learning time and 
ultimately ease incorporation into current practice. Furthermore, improved 
understanding and reporting of rheological properties will lead to better 
theoretical explanations of how materials affect rheological performances, to 
better predict and design the next generation of biomaterials. 
 
Introduction 
 Hydrogels are water-swellable networks held together by physical and/or 
covalent crosslinks. These networks can be tailored with varying degrees of 
control of the structural architectures from nano- to microscales and made from 
a wide variety of materials to suit particular applications.(1) Conventional 
hydrogel networks can be made from biological polymers (especially proteins and 
polysaccharides), synthetic polymers (e.g., poly(ethylene glycol)), or chemically 
modified (semi-synthetic) biopolymers such as cellulose ethers. Less 
conventional gels can be formed from inorganic colloids or even constructed from 
harvested tissues.(2-8) The molecular properties (e.g., hydrophilic/hydrophobic 
balance, net charge or charge distributions) and macroscopic physical properties 
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(e.g., size) can be tuned based on the desired application.(9) Hydrophilicity and 
significant water content (typically in the 50-90% range) and a fixed physical 
geometry once the gel has formed are the defining features that fall under the 
broadest sense of the term ‘hydrogel’. The versatility of hydrogels has allowed 
them to be employed in a wide variety of applications, from consumer products 
such as diapers to various foods to common biomedical devices such as soft 
contact lenses.(10-18) Hydrogels have contributed to the rapid growth in 
publications for more complex biomedical engineering applications such as tissue 
engineering constructs and triggered drug delivery devices over the past 20 
years.(19, 20) Most publications characterizing hydrogels focus on the 
performance of the gel after it has formed, with far less attention being paid to the 
behavior prior to gelation. For successful translation to surgical applications, the 
behavior of the pre-gelled solution is critical. 
  The use of hydrogels in regenerative medicine and biomedical 
applications has been rapidly increasing over the past 20 years, as the potential 
of hydrogels to treat complex medical issues has become widely recognized.(21)  
In situ forming hydrogels - those that polymerize or set within the body - can be 
applied to the treatment of  a wide range of complex medical issues such as those 
requiring filling of defects of various shapes and sizes. Hydrogels can be used to 
encapsulate and localize both living cells and materials such as hydroxyapatite 
(HAp) and demineralized bone matrix (DBM). HAp and DBM are commonly used 
materials in hydrogel formulations for treatment of bone defects.(16, 22) DBX® is 
a widely used commercially available bone replacement product that combines 
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DBM and hyaluronic acid, the DBM concentration in these hydrogels modulates 
material pliability to achieve either paste or putty behavior for in situ 
placement.(16) In fluid mechanics, the yield stress is the stress required for a fluid 
to begin to flow (as opposed to solid mechanics, where the same ‘yield stress’ 
term refers to the point between elastic and plastic deformation), and quantifies 
where such a fluid lies on the spectrum of paste to putty behavior. Increasing the 
yield stress allows for different material consistencies as illustrated in Figure 2.1, 
in which materials with no yield stress exhibit traditional liquid behavior (i.e., flow 
upon exposure to any stress, no matter how small), while materials with 
increasing yield stress have paste or putty behavior. DBX® products, for example, 
vary the yield stress based on the application, employing high yield stress putties 
for craniofacial applications and lower yield stress pastes for filling mandibular 
resection defects.(23) The major difference between paste or putty being the 
route of application, where high yield stress materials can be easily molded and 
lower yield stress materials can easily flow for injection.  
 Materials with handling properties that are similar to current products 
familiar to surgeons would have lower-learning curves associated with them and 
thus would be easier for them to adopt. To quantitatively assess these properties, 
we propose the use of rheology instruments to measure precursor solution 
characteristics such as yield stress, which have direct relevance to clinicians’ use 
of the materials. In practice, the three most relevant rheological parameters are 
the ease of injection (shear response), time for placement (recovery time), and 
retention of the hydrogel precursor solution at the defect site (yield stress). A 
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review of the recent literature revealed 27 studies that have conducted hydrogel 
precursor rheology for one or more of the three previously mentioned properties 
of interest to clinicians (Table 2.1). Of these 27 studies, only 10 characterized all 
three rheologically dependent characteristics. Although research publications 
commonly state the ability of the hydrogel precursor solution to be injectable or 
fill any irregularly-shaped defect, few publications reporting new hydrogels 
actually characterize the precursor solution. Various groups have reported their 
material to be injectable based only on the ability to pass through a syringe 
needle. Similarly, investigators have reported gel formation as determined by a 
simple tube inversion observation.(24, 25) Wang et al.(26) demonstrated that a 
mixture of oppositely charged nanospheres of anionic and cationic gelatins could 
be injected into a conical tube and inverted while maintaining the position and 
shape. Although these methods may qualitatively identify yield stress behavior 
and/or shear thinning properties, they do not provide quantitative or definitive 
information.  
 Therefore, the purpose of this review article is to emphasize to 
biomaterials developers the importance of hydrogel precursor rheological 
characterization. The connection between rheological properties and surgical 
application requirements will be explained, and how medical nomenclature can 
be leveraged as a translational advantage among hydrogel formulation 
developers. Finally, rheological modeling is proposed as the basis for comparison 
among hydrogel precursor groups, with additional considerations for physical, 
chemical, and combinational crosslinking approaches proposed to help move the 
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community toward material design strategies to create precursor solutions with a 
target yield stress. In this review, we will show how implementing yield stress in 
hydrogel precursor solutions has a direct benefit for biomedical applications in 
terms of clinical translation.   
 
Biomedical Hydrogel Perspective 
Our Inspiration 
 More than 20 years ago, the concept of colloidal gels began to emerge as 
a potential material for regenerative medicine. At the time, pioneering work by 
Prof. Jennifer Lewis and others showed novel colloidal inks could be used for 
printing freestanding 3D structures.(27, 28) Such colloidal inks utilized weak 
interactions between a multitude of nanoparticles or between nanoparticles and 
polymers, which could be disrupted to allow the viscous ink to yield and flow 
before again ‘recovering’ bulk solid properties. We and others recognized these 
dynamic, viscoelastic colloidal inks offered promise as tissue fillers or as 
substrates for printing 3D scaffolds for regenerative medicine.(29, 30) 
Our team began translating colloidal gels to applications in regenerative 
medicine based on biodegradable materials suitable for use as tissue fillers while 
still maintaining the desirable properties of colloidal inks. We rationalized that 
these dynamic, viscoelastic and biodegradable colloidal gels could facilitate 
placement of the material, retention at the site of administration, and recovery of 
elasticity after placement. Our first effort employed combinations of poly(lactic-
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co-glycolic acid) (PLGA) nanoparticles with opposite surface charges, which we 
demonstrated could support viable cells.(31) This work was followed by a study 
showing zero-order release and in vivo suitability for cranial defect repair.(32) 
Moving in a new direction, we then demonstrated that hyaluronic acid 
nanoparticles could form a dynamic, viscoelastic material believed to be the result 
of association of free surface chains, resulting in a colloidal gel viscosupplement 
that might improve upon the performance of traditional crosslinked or high 
molecular weight hyaluronic acid.(33) Having demonstrated some fundamental 
properties of colloidal gels, we then reported efforts to improve material 
performance by adding colloids such as hydroxyapatite,(34) or creating colloidal 
gels that could be chemically crosslinked after placement.(35) Today, we 
continue to explore the performance of colloidal gels in vivo as injectable bone or 
cartilage fillers, and we are refining material properties to create clinician-friendly 
materials that promote tissue regeneration.(36, 37)  
The precursor properties of our materials are of critical importance to 
clinicians, perhaps even more so than the crosslinked solid mechanics, 
depending on the application. That is, it is important to have a material that is 
easy to place in the site and ensure that it will stay there, and that if new hydrogel 
precursor solutions have behaviors of other moldable materials that surgeons are 
used to implanting, they may be more likely to adopt the technology. 
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Translation of Technology to Surgeons 
 In designing new hydrogel technologies with clinical translation as an end 
goal, it is important to keep in mind the needs of the clinician and the patient 
throughout the process. The transition from lab bench to clinic can be an arduous 
process, and a potentially significant product could be completely ignored if the 
surgeon must acquire new skills or buy new equipment. Wilson et al.(38) 
proposed that surgeons are attracted to new medical technologies that can be 
learned by passive observation rather than hands-on training sessions, and thus 
can be easily adopted into their practice without disruption. The gap between 
scientific knowledge and clinical application is well known, and with decreasing 
time available for some clinicians to spend on research, there are less 
comparative studies being conducted.(39) New methods are being employed to 
shorten the learning curve associated with new medical technologies and surgical 
procedures. The use of social media outlets and live streaming has provided the 
ability for surgeons to collaborate on difficult cases and provide coaching 
between surgical teams from different continents.(40, 41) Although steps are 
being taken to ease the translation of new research into the clinic, it is always 
going to be easier to utilize a surgeon’s current skill-set than to require training in 
a new technique. 
 Lack of consideration of the method for the physical placement of 
hydrogels in an intended application directly ignores the needs of the surgeon. In 
the example of in situ hydrogels for cartilage regeneration, some groups have 
proposed the use of liquid hydrogel precursors with zero yield stress to fill defects 
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before crosslinking.(42) The issue with this hydrogel precursor design is that it 
does not account for applications in which the defect may be angled, or in a hard 
to access area. In vivo studies generally employ ideal situations, such as a defect 
site that is perfectly cylindrical and applied to a single plane.(43) In contrast, real 
tissue defects are not perfectly cylindrical and uniplanar, as illustrated in Figure 
2.2. In situ placement using a liquid hydrogel precursor solution with zero yield 
stress could become difficult as the material may leak after placement. In 
designing clinically translatable hydrogels, understanding the connection 
between rheological hydrogel precursor properties and the connection to surgical 
use is important for successful clinical translation. 
 
Biomedical Hydrogel Perspective Summary 
 Over the past 10 years, we have evolved from using simple colloidal gels 
to more complex crosslinkable hydrogels for biomedical applications. A core 
philosophy of our team has focused on creating biomaterials capable of being 
translated from the lab to the clinic. A challenge of clinical translation is the poor 
adoption of new treatments by surgeons if the technique learning curve is too 
high. For the aforementioned reason, we have identified the handling properties 
of hydrogels, specifically the hydrogel precursor performance, as a crucial 
component of hydrogel design to allow future clinical translation.  
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Surgical Context 
Injectability/Syringeability and Shear Properties 
“Injectability” is a common buzzword among hydrogel publications to qualitatively 
communicate the ability of a material to flow through a syringe needle.(34, 44-47) 
Although prevalent, the use of this term is generally ambiguous with minimal 
quantitative information provided, as the injection pressure is strongly correlated 
with injection rate, needle gauge and length (i.e., the Hagen-Poiseuille equation). 
A similar term that has been used much less frequently in hydrogel publications 
is syringeability, which has become useful in our own publications to express the 
ability of the hydrogel precursor solution to flow through a syringe orifice rather 
than a needle.(2, 48) Both terms, injectability and syringeability, qualitatively 
express the ability to flow through a certain orifice size. In relation to the medical 
field, the performance of a material to easily flow from a needle or a syringe can 
dictate the delivery method and use by the surgeon. An injectable material (i.e., 
through a needle) could potentially have applications in laparoscopic surgery, 
whereas a syringeable material (i.e., through a syringe orifice) may require open 
surgery for placement. 
 The flow of a material in both situations is governed by the shear response 
exhibited when a force is applied as a function of flow rate. During extrusion, the 
material can undergo shear thinning or shear thickening. Shear thinning is where 
a material will exhibit a decreasing apparent viscosity with increasing rate of 
applied stress (i.e., shear rate), whereas shear thickening is where the material 
will exhibit an increasing apparent viscosity with increasing rate of applied stress. 
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The apparent viscosity can also be time dependent (i.e., thixotropy or rheopecty); 
however, the instantaneous change when a stress is applied is of more 
importance for application to biomedical materials as syringing or injection occurs 
over a short period of time. Hydrogel precursor solutions generally exhibit shear 
thinning behavior, which makes delivery from a syringe easier because as the 
shear rate increases in the needle, shear thinning will reduce the apparent 
viscosity and thus the relative resistance to flow (Table 2.1). Fakhari et al.(49) 
demonstrated shear thinning performance of colloidal gels comprised of 
hyaluronic acid nanoparticles by showing a decreasing viscosity with increasing 
shear rate. Similarly, Tsaryk et al.(50) indicated shear thinning performance of 
collagen/hyaluronic acid semi-interpenetrating network loaded with gelatin 
microspheres by determining the load required to inject the material through a 
16-gauge needle, showing a decreasing force required after the material began 
to flow. We previously fit experimental rheological data to the Herschel-Bulkley 
equation to determine the shear response, which allowed for a quantitative and 
comparable method for the degree of shear thinning.(34, 35, 51) The need for 
shear thinning physical hydrogels was previously identified by Guvendiren et 
al.(52) in biomedical applications; however, the benefit of shear thinning behavior 
can be extended to all hydrogel precursors. Shear thickening behavior has 
generally been avoided in biomedical applications due to issues with extruding, 
although desired in some industry based applications.(53) After injection or 
syringing, it is important for the material to regain the original properties prior to 
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being injected or syringed. The time required for transition back to this starting 
time is referred to as the recovery time.  
 
Placement and Recovery Time 
 Prior to injection or syringing, the bulk material is static and the 
microstructure is stable. After disruption, the material properties are in a state of 
disarray and take time to return to equilibrium. The time required for a material to 
return to the original equilibrium state is referred to as the recovery time, or the 
self-healing time.(52) The governing principle associated with the material 
recovery time is referred to as thixotropy, the reversible and time-dependent 
manifestation of viscosity-induced structural changes.(54-56) The recovery time 
of a syringed material is important in terms of initial placement. A material with a 
relatively slow recovery time could potentially have issues during placement as 
the material would initially be difficult to retain within the defect site. In terms of 
clinical usage, a fast recovery time after syringing is necessary for material 
manipulation or shaping, and especially for placement laparoscopically where it 
would be difficult to implement precautions for increased material retention. The 
recommended recovery time, and degree of material recovery for syringed or 
injected materials has yet to be defined and remains application dependent. We 
previously proposed the use of colloidal hydrogels comprised of hyaluronic acid, 
hydroxyapatite, and micronized native extracellular matrix as potential bone 
defect fillers.(57) The physical hydrogels presented were capable of nearly 
complete recovery of the storage modulus (G’) within 5 minutes after disruption 
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(Table 2.1). Similarly, in a previous study, we reported hydrogels comprised of 
UV-crosslinking hyaluronic acid and hyaluronic acid nanoparticles, in which the 
precursor could recover their original storage modulus within 5 minutes.(35) Even 
faster recovery times on the magnitude of seconds have been reported.(45, 47, 
58) Gaharwar et al.(59) demonstrated that an injectable nanocomposite hydrogel 
of gelatin and synthetic silicate nanoplatelets could be used for the treatment of 
internal hemorrhaging, as the hydrogel could recover the elastic gel strength in 
less than 10 seconds after disruption. In general, materials for biomedical 
applications should aim to have low recovery times to facilitate ease of use. After 
shearing and material placement, the material must remain in place, this retention 
is influenced by the yield stress of the material.  
 
Retention and Yield Stress 
 The stress required for a material to begin to deform under an applied 
shear stress is referred to as the yield stress, and it plays an important role in 
material performance. The yield stress is entirely separate from the apparent 
viscosity, and these two terms must not be confused. The yield stress contributes 
to both the syringeability/injectability of the material (i.e., initial force required to 
generate flow) and retention within the defect after placement (i.e., no movement 
in the absence of applied force). In contrast, the apparent viscosity relates to the 
force required to continue dispensing from the syringe after flow has commenced. 
Implementation of yield stress to the hydrogel precursor solution can positively 
aid in material retention within the defect site after surgical placement. Figure 2.3 
 
 
20 
 
illustrates the placement of a hydrogel precursor solution without a yield stress 
compared to a hydrogel precursor solution with a yield stress (i.e., exhibiting 
paste or putty rheological properties). Precursor solutions enabling a yield stress 
will experience better retention in the defect site, allow for shape-specific fitting, 
and will be easier for surgeons to handle.(51) Various methods are currently used 
to determine a material yield stress as depicted in Figure 2.4. The most common 
methods include 1) empirical model fitting (e.g., Herschel-Bulkley), 2) determining 
the shear stress at the crossover point of the storage and loss modulus (G’/G”), 
and 3) determining the shear stress related to a pre-determined deviation of 
storage modulus from linearity. We previously used a three-parameter fitting 
technique to the Herschel-Bulkley model to report the yield stress of UV-
crosslinking hyaluronic acid hydrogels embedded with hyaluronic acid 
nanoparticles, and reported yield stress values in the range of ~18 to 160 Pa 
(Table 2.1).(51)  Similarly, in another study, we used the Herschel-Bulkley model 
to determine the yield stress of hydroxyapatite colloidal gels with either hyaluronic 
acid or chondroitin sulfate, the resulting yield stress ranged from ~1 to 1400 
Pa.(34) Alternatively, Olsen et al.(60) demonstrated that hydrogels comprised of 
self-assembling telechelic proteins had a yield stress of ~1400 Pa using the G’/G” 
crossover method, and could be injected from a syringe through a 22-gauge 
needle. Similarly, Liu et al.(61), Gao et al.(62), and Yu et al.(63) used the G’/G” 
crossover method to determine yield strains of 9.8, 78, and 130%, respectively. 
Yield strain, similar to yield stress, is the strain at which a fluid begins to flow. We 
previously used the storage modulus deviation method, choosing a storage 
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modulus deviation of 10% from linearity, to determine the yield stress range of 
colloidal hydrogels comprised of hydroxyapatite and glycosaminoglycans from ~1 
to 1400 Pa.(57) Gaharwar et al.(59) and Glassman et al.(46) similarly used the 
deviation from linearity method in determining the yield stress. As a general rule, 
yield stress values above 100 Pa are sufficient for material retention prior to 
secondary crosslinking.(2, 49, 59)  
 Hydrogel precursor solutions can be created with a yield stress by several 
different available options. Perhaps the easiest route to employ a yield stress is 
the addition of micro- or nano-sized particles, the reduction in available space 
results in a thicker consistency, and we have previously used this method to 
create a hydrogel precursor solution with a yield stress.(36) Dumas et al.(64) 
developed an injectable self-setting lysine-derived polyurethane scaffold 
encapsulating allograft bone particles (180 m) for bone restoration. Allograft 
bone particles were added to the precursor solution at a concentration of 45% 
(w/w), providing a modest yield stress of 2.1 Pa. An alternate route to employ a 
yield stress to a precursor solution is the use of oppositely charged materials, 
where electrostatic interactions increase precursor consistency. Gaharwar et 
al.(59) used oppositely charged gelatin and silicate nanoplatelets to create 
injectable self-assembling hydrogels for treatment of internal hemorrhaging. The 
oppositely-charged gelatin-silicate nanocomposite hydrogels provided a yield 
stress of 2 to 89 Pa, depending on nanoplatelet concentration. Another potential 
avenue for achieving a precursor yield stress is the use of fast-acting click 
chemistry to create materials that self-heal after shearing. For example, Yu et 
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al.(63) proposed the use of a self-healing multi-block copolymer capable of 
quickly forming covalent bonds between acylhydrazines and aldehyde groups. 
Rapid covalent bond formation allowed for material healing after injection, 
creating a dynamic material with many potential applications to regenerative 
medicine. 
 
Rheological Methods 
 The assessment of rheological performance can be attained by various 
rheological testing systems. For in-depth background information regarding the 
mathematical theories of rheological testing, an introductory polymer rheology 
textbook by Osswald et al.(65) is recommended. Briefly, the two most commonly 
used testing fixtures, cone-plate and parallel-plate, will be discussed, detailing 
their individual uses and strengths/weaknesses. The cone-plate fixture allows for 
a wide variety of rheological tests such as yield stress, creep, recovery time, 
oscillation, and ramp tests.(65) The wide variety of rheological tests can be 
attributed to the design of the cone-plate fixture, where an upper cone of a small 
angle, generally between 1-4°, sandwiches the material being tested between a 
flat bottom plate. Due to the small angle of the cone, the shear rate and shear 
stress across the sample is nearly constant, allowing for accurate material 
measurements. The disadvantage of the cone-plate system is that it is limited to 
small particle sizes (≤ 10 µm), and thus cannot be used for suspensions of larger 
particles. Alternatively, the parallel-plate fixture, which sandwiches the material 
being tested between two flat plates, is not limited by particle size. Due to the 
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design of the parallel plate fixture, materials with larger particle sizes (≥ 10 µm) 
can be tested. The disadvantage of the parallel-plate fixture is that the shear rate 
across the sample increases with radius, so the parameters obtained are average 
values over the range. while keeping in mind that these differences exist in 
comparing results between various studies. The cone-plate fixture is the 
recommended choice when performing a rheological test; however, in cases 
where the cone-plate fixture may not be used due to particle size, the parallel-
plate fixture is recommended. The choice of testing apparatus, and the geometry 
of the probing fixture can influence the resulting data provided by a rheological 
test. Testing differences must be noted as sample measurements conducted by 
two separate studies using the same material and testing conditions, but different 
testing fixtures, can have varying results. It is necessary to report the choice of 
testing apparatus (e.g., cone-plate or parallel-plate), fixture geometry (e.g., 20 
mm), and testing conditions, while keeping in mind that methodological 
differences exist in comparing results among various studies. The cone-plate 
fixture is the recommended choice when performing a rheological test; however, 
in cases where the cone-plate fixture may not be used due to particle size, the 
parallel-plate fixture is recommended.  
 
Surgical Context Summary 
 The connection between rheological terminology and parameters 
observed in clinical practice is important for any researcher in developing the next 
generation of hydrogels intended for clinical adoption. In this section, we have 
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outlined the connection between injectability/syringeability and shear properties, 
material placement and recovery time, and material retention and yield stress to 
help bridge the gap between rheology and clinical relevance. Table 2.1 
summarizes the rheological properties of published hydrogel precursor solutions. 
In general, we recommend that the design of in situ forming hydrogels for use in 
biomedical applications includes shear thinning properties that are application 
dependent for either injection through a needle or syringe orifice, incorporates an 
adequate recovery time after disruption to minimize any loss of material, and has 
a suitable yield stress (>100 Pa) to allow for material retention and shape fitting. 
Additional background information on rheological application has been provided, 
focusing on choosing the best testing fixture for the material being studied. The 
cone-plate fixture is recommended overall, but limited to materials with small 
particle sizes (≤ 10 µm), and the parallel-plate fixture is recommended for 
materials with larger particle sizes (≥ 10 µm). Implementing desired rheological 
performance in various hydrogel designs can be challenging, and considerations 
for implementing these properties are proposed below.       
 
Hydrogel Rheology Properties 
Paste and Putty Nomenclature 
As previously stated, paste and putty nomenclature has long been used in 
medical products to distinguish basic rheological properties.(16) Medical 
professionals and the general public already have a common connection to these 
words and their distinguishing characteristics. The paste and putty description is 
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directly related to a material’s rheological properties for placement, specifically 
the material’s yield stress. A low yield stress material would exhibit paste-like 
properties and a high yield stress material would exhibit putty-like properties.(31, 
66) Because of the pre-existing connection to paste and putty nomenclature, the 
biomedical hydrogel community would be wise to adopt these words in describing 
rheological characteristics. 
The distinction between paste and putty performance, although related to 
yield stress, remains qualitative and has yet to be successfully defined. In part, 
this review aims to propose relative ranges of yield stresses for both paste and 
putty solutions for improvement of material reporting. In determining the yield 
stress range for a paste-like material compared to a putty-like material, we can 
utilize known materials to help in creating the distinction between the two 
designations. Samaniuk et al.(67) previously published yield stress values for 
common household items that qualitatively exhibit either paste or putty behavior 
for reporting the design of a novel rheometer, specifically the yield stress values 
for mayonnaise and Play-Doh. The yield stress of mayonnaise and Play-Doh, 
approximately 200 and 3000 Pa, respectively, can be used to help define the 
ranges for paste and putty distinctions. Using the yield stress of known household 
items and previous publications from our own group, we have proposed the range 
of 100 to 2000 Pa for paste-like materials and materials above 2000 Pa to exhibit 
putty-like properties. By reporting material yield stress in these parameters, it is 
possible to better connect the hydrogel community to clinicians using a common 
set of nomenclature.  
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Paste and Putty Application 
 The choice between paste and putty behavior for hydrogel precursors 
remains application dependent, and no “one size fits all” approach exists. 
Examples of low yield stress, paste-like hydrogel precursors, and high yield 
stress, putty-like hydrogel precursors will be explored and how they can be 
beneficial to different applications. Nucleus pulposus regeneration and 
ophthalmetry are two areas in which hydrogel use has been proposed.(68-71) 
The aforementioned applications generally propose precursor solutions to exhibit 
low to no yield stress for injection through a high-gauge needle; however, low 
yield stress, paste-like hydrogel precursor solutions may be ideal for such 
applications as they allow for injection through higher gauge needles while 
providing benefits tailored to the application desired.(72-74) High yield stress, 
putty-like hydrogel solutions are generally useful in applications where shape 
fitting is required, such as craniofacial bone regeneration.(75, 76) The higher 
yield stress precursor solutions and physical gels allow for better material shaping 
and directed tissue regeneration.  
 
Herschel-Bulkley Model 
 Although paste and putty nomenclature qualitatively depicts low and high 
yield stress, the nomenclature alone does not provide enough information for an 
in-depth comparison. It is important for the hydrogel community to choose a 
standardized testing method that allows for a deeper look into the relationships 
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between material properties and rheological performance. When reporting 
rheological properties of new materials, it is beneficial to fit experimental data to 
common, pre-existing rheological models for comparison. The Herschel-Bulkley 
(HB) model is an ideal candidate to fill this need for the hydrogel community. The 
HB model was first introduced by Winslow Herschel and Ronald Bulkley in 1926 
and provides a simple and general model to explain the behavior of a non-
Newtonian fluid.(77) The HB model equation shown in Equation 1 relates the 
fluids shear stress (𝜏), to the yield stress (𝜏0), consistency index (𝑘), shear rate 
(?̇?), and flow index (𝑛). 
𝜏 =  𝜏0 + 𝑘?̇?
𝑛     (Equation 1) 
The fluid exhibits solid properties when 𝜏 < 𝜏0, and for 𝜏 > 𝜏0, exhibits shear 
thinning when 𝑛 < 1 and shear thickening when 𝑛 > 1.  The HB model is an 
attractive option for the hydrogel community because it provides a general model 
that includes variables for both yield stress and shear response. Previous groups 
that have characterized hydrogel precursor solutions have reported that 
experimental results respect the HB model.(78-80) For reporting hydrogel 
precursor properties, quantification of yield stress and shear response 
adequately provides information for comparison of materials within the hydrogel 
community.  
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Summary  
Understanding the nomenclature between clinicians and scientists is 
important for bridging the gap between the two fields. By incorporating the 
nomenclature, and defining the parameters, it is possible to better connect the 
two sides and eliminate the possibility of failed medical translation due to issues 
of poor surgeon adoption. In this section, we have defined the yield stress 
attributing to paste and putty nomenclature as the range of 100 to 2000 Pa, and 
materials above 2000 Pa, respectively. The application dependency of paste and 
putty precursors were explored, and the Herschel-Bulkley model was proposed 
as a simple model for reporting rheological parameters such as yield stress. The 
recommended range for paste and putty materials, and use of the Herschel-
Bulkley model, will hopefully increase the reporting of rheological parameters for 
clinical translatability. 
 
Hydrogel Precursor Considerations 
Chemically Crosslinked Hydrogels 
 Chemically crosslinked hydrogels are distinguished by the creation of 
covalent bonds between polymers to form an interconnected network.(21) A 
number of varying methods have been proposed to achieve the crosslinked 
network, the most common being photo-initiation, and enzymatic/reaction based 
technologies.(81-83) Various groups have proposed new and insightful ways for 
the development and application of chemical hydrogels for regenerative 
medicine; however, the delivery method of the pre-crosslinked form is often 
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unclear and under-characterized.(83, 84) Choi et al.(85) developed a novel 
visible light crosslinking chitosan hydrogel encapsulating collagen II and TGF-β3 
for in situ cartilage regeneration. The technology developed has shown promise 
for the reported application; however, the intended delivery mechanism and 
subsequent material mechanical characterization were not clearly identified. In 
designing chemically crosslinked hydrogels for regenerative medicine, it is 
important to establish a delivery method suitable for the intended user that 
facilitates the ease of placement, and characterize these rheological 
properties.(86) Although some groups have proposed circumventing the need for 
in situ placement by crosslinking the hydrogels in Teflon molds, the pre-
crosslinking method arguably diminishes the potential of this technology.(87)  
Although the end result of photo-initiated and reaction-based in situ hydrogels 
are similar in many ways, the considerations for designing their placement are 
distinct.    
 Photo-initiated hydrogels combine the positives of user-defined 
crosslinking initiation with the ability to form tunable covalent bonds to modulate 
crosslinking density.(81, 88) The downside of this method involves the need for 
an outside light source for initiation, generally requiring an open surgical site. The 
necessity of the open surgical site limits the available applications of photo-
initiated hydrogels; however, an open surgical site offers many potential benefits 
for precursor solution placement. Photo-initiation allows for complete control over 
the precursor placement, enabling possible shaping and defect-fitting if the 
precursor exhibits the correct rheological properties. Earlier, we  proposed the 
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idea of a photo-initiated hydrogel that could allow for easier surgical placement 
in cartilage defects if the precursor solution exhibited a sufficient yield stress, 
enabling a surgeon to form-fit the material to the defect site before crosslinking.(2, 
35, 48, 89) A potential limitation of photoinitiated hydrogels is the requirement for 
light penetration, thus opaque materials may encounter crosslinking issues due 
to limited light penetration. Reaction-based hydrogels, which are not limited to 
opacity issues like photoinitiated hydrogels, are generally initiated by the mixing 
of two solutions to initiate crosslinking and subsequent hydrogel formation.(24) 
Due to the need for achieving a well-mixed solution, many studies utilized low 
viscosity, zero yield stress precursor solutions.(90, 91)  Although these hydrogels 
have shown great promise in promoting cell viability and proliferation, the these 
hydrogels may encounter limitations in the intended surgical application. 
Employing a yield stress to the mixed precursor solution can greatly increase the 
available applications for reaction-based hydrogels.(44, 92) Special 
considerations need to be made for reaction-based hydrogels that employ a 
precursor yield stress. Issues arise in achieving a well-mixed solution, and an 
external mixing system such as a dual-syringe and mixing tip may be required. 
For both photo-initiated and enzymatic/reaction hydrogel precursor solutions, it is 
strongly recommended to characterize and report the yield stress, recovery time, 
shear response, and gelation time at physiological conditions.  
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Physically Crosslinked Hydrogels 
Physical hydrogels are classified as hydrogels held together by polymer 
entanglements and/or secondary forces, and unlike chemical hydrogels, no 
formation of covalent binding occurs.(21) Some common methods for forming 
physical hydrogels are based on charge, colloidal flocculation, peptide 
interactions, and physical thermogelation.(25, 47, 93-97) Compared to 
chemically crosslinked hydrogels, physical hydrogels require specific rheological 
considerations as chemical binding does not occur post-placement. Physical 
hydrogels that exhibit a moderate yield stress, shear thinning behavior, and quick 
recovery time are ideal for biomedical applications.(34)  Many research groups 
proposing the use of physical hydrogels for biomedical applications have 
characterized a wide variety of rheological properties.(49, 59) Lu et al.(47) is a 
prime example of a physical hydrogel mechanical characterization study using 
rheology, providing information on shear response, gel recovery time, and yield 
stress/strain.  
 Physical hydrogels based on charge, colloidal flocculation, and peptide 
interactions require the same rheological considerations. In designing physical 
hydrogels for biomedical applications, certain key rheological properties must be 
characterized and reported. Evaluation of yield stress, recovery-time, and shear 
response are strongly recommended when reporting new physical hydrogels to 
the community. Additionally, physical hydrogels for biomedical applications must 
be tested at body temperature as a proof of concept. Physical hydrogels utilizing 
thermogelation require the same considerations as the charge, colloidal, and 
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peptide hydrogels; however, additional tests must be taken into consideration. 
Viscoelastic properties of thermally activated hydrogels should be mapped at 
varying temperature, and the time required for gelation at body temperature 
should be characterized.  
 
Combinational Crosslinking Hydrogels 
 Combinational hydrogels are developed with the intention of utilizing both 
physical and chemical crosslinking principles in mind. Hydrogels have historically 
been separated as either chemically or physically crosslinked; however, there are 
potentially great benefits for hydrogel designs incorporating both physical and 
chemical crosslinking principles.(98) Lu et al.(4) proposed the use of a 
combinational crosslinking hydrogel utilizing both self-assembling peptides and 
secondary UV-crosslinkable hyaluronic acid to form covalent bonds. Other 
groups have proposed the use of combinational hydrogels, such as polymer 
entanglements combined with UV-crosslinking, and thermogelation combined 
with reaction based crosslinking.(98, 99) The rheological considerations for the 
combinational hydrogel precursors should incorporate the necessary  
experimental tests for both physically and chemically crosslinked hydrogels, as 
previously mentioned. 
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Crosslinking Hydrogels Summary 
In this section, considerations for hydrogels incorporating chemical, physical, and 
combinational crosslinking mechanisms have been summarized. A general 
outline of rheological considerations and characteristics to report have been 
provided for each of the mentioned cases. The implementation of yield stress to 
precursor solutions can positively impact all hydrogel types and allow for an 
easier translation from the lab to clinic, while minimizing surgeon learning curve.  
 
Conclusions 
 In the current review, we have summarized the need for hydrogel 
precursor rheological characterization and the advantage of implementing 
precursor solutions exhibiting yield stress for surgical placement. This review has 
explored the gap in translation between hydrogel technology and clinical 
application, and identified the rheology of the hydrogel precursor solution as an 
often overlooked, yet crucial, design consideration. Basic rheological principles 
and their connection to the medical world have been explored, providing 
examples of recent research in application-dependent hydrogel design. Common 
pre-existing nomenclature of paste and putty behaviors were introduced for 
explaining low and high yield stress precursor properties, and the Herschel-
Bulkley equation was proposed as the model to be used by the hydrogel 
community in reporting rheological properties for comparison. Considerations for 
hydrogels utilizing chemical, physical, and combinational crosslinking 
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mechanisms were explored to better inform the community in designing new 
hydrogel materials for ease of implantation and surgeon adoption. 
  Hydrogels proposed for tissue engineering and regenerative medicine 
applications ultimately aspire to translate from the lab bench to the clinic. The 
design and intended placement of hydrogels may be tailored specifically with the 
surgeon in mind, minimizing the surgeon learning curve to ultimately improve 
translation. An emphasis within the hydrogel community on reporting rheological 
properties of hydrogel precursor solutions is the first step for meeting the clinical 
need. By utilizing the Herschel-Bulkley equation, the hydrogel community can 
easily compare rheological properties in a general and simplified manner that 
minimizes the need for an in-depth understanding of rheology. By better 
characterizing and reporting rheological performance of hydrogel precursor 
solutions, the community can begin to work toward theoretical explanations rather 
than relying on empirical correlations. By quantifying relationships rooted in 
fundamentals, future research will allow for better prediction and rational design 
of precursor solutions. Furthermore, research into precursor rheology will directly 
benefit other areas of research such as 3D bioprinting applications, which rely on 
achieving a specific yield stress for extrusion, a hot area in bioink research 
today.(100-102) We suggest a dialogue bringing together experts in both non-
Newtonian fluids and hydrogels, to facilitate an understanding of how to 
characterize and design better biomaterials. This dialogue will help to bridge the 
gap in knowledge regarding non-Newtonian rheology and establish new 
collaborations across different fields.  
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Chapter 3: Colloidal Gels with Extracellular Matrix Particles and 
Growth Factors for Bone Regeneration in Critical Size Rat 
Calvarial Defects2 
 
Abstract 
Colloidal gels encapsulating natural materials and exhibiting paste-like properties 
for placement are promising for filling complex geometries in craniofacial bone 
regeneration applications. Colloidal materials have demonstrated modest clinical 
outcomes as bone substitutes in orthopedic applications, but limited success in 
craniofacial applications. As such, development of a novel colloidal gel will fill a 
void in commercially available products for use in craniofacial reconstruction. One 
likely application for this technology is cranial reconstruction. Currently, traumatic 
brain injury (TBI) is often treated with a hemi-craniectomy, a procedure in which 
half the cranium is removed to allow the injured brain to swell and herniate 
beyond the enclosed cranial vault. The use of colloidal gels would allow for the 
design of a pliable material capable of expansion during brain swelling, and 
facilitate cranial bone regeneration alleviating the need for a second surgery to 
replace the previously removed hemi-cranium. In the current study, colloidal 
nanoparticles of hydroxyapatite (Hap), demineralized bone matrix (DBM), and 
decellularized cartilage (DCC) were combined with hyaluronic acid (HA) to form 
   
2Published as: Townsend JM, Dennis SC, Whitlow J, Feng Y, Wang J, Andrews B, Nudo RJ, 
Detamore MS, Berkland CJ. Colloidal Gels with Extracellular Matrix Particles and Growth 
Factors for Bone Regeneration in Critical Size Rat Calvarial Defects. The AAPS Journal. 
2017;19(3):703-11. doi: 10.1208/s12248-017-0045-0 
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colloidal gels with desirable rheological properties (𝜏y ≥ 100 Pa). BMP-2 and 
VEGF growth factors were included to assess extracellular matrix (ECM) 
contribution of DBM and DCC. The HA-Hap (BMP-2) and HA-Hap-DCC group 
had 89 and 82% higher bone regeneration compared to the sham group, 
respectively (p < 0.01). Material retention issues observed may be alleviated by 
implementing chemical crosslinking. Overall, DCC may be a promising material 
for bone regeneration in general, and colloidal gels may hold significant potential 
in craniofacial applications. 
 
Introduction 
 Colloidal gels represent a promising class of injectable materials for use 
in tissue engineering and regenerative medicine applications because of their 
high water content, self-assembly, tunable mechanical properties, and 
implementation of physical crosslinking for minimally invasive delivery.(35) The 
use of physical crosslinking principles in the development of colloidal hydrogels 
has resulted in the creation of highly tunable rheological properties capable of 
exhibiting yield stress for surgical placement and material recovery after 
injection.(47, 49, 52) In our previous studies utilizing colloidal gel technologies, 
these properties have been mapped using polymers and colloidal particles to 
achieve “paste-like” properties ideal for surgical placement.(34, 35) One clinical 
specialty that will greatly benefit from colloidal gel technology used for bone 
regeneration is craniofacial surgery.(103) Previous studies have demonstrated 
that similar colloidal gels have shown promise in bone tissue engineering 
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applications, highlighting the use of biodegradable natural materials as an 
attractive alternative to current commercially available options.(31, 66) 
 Current commercial products have demonstrated a long track record of 
clinical success in orthopedic long bone regeneration; however, many 
craniofacial applications are limited by current product designs and physical 
properties.(16) In particular cranial reconstruction has been problematic due to 
the large contoured surface area, the constant repetitive pulsation of the 
underlying dura/brain, limited soft tissue coverage options, and sensitivity of the 
underlying brain tissue to exothermic biomaterial processes.  Commercially 
available products such as DBX (MTF/Synthes), Dynagraft II (Integra 
Orthobiologics), Grafton® Gel (Osteotech), and Puros® DBM (Zimmer) have had 
limited success in calvarial reconstruction due to the low availability of 
propriogenic stem cells in the cranial diploic space as compared to that of long 
bones and the inability of all biomaterials to overcome a critical cranial defect 
size. These limitations of current commercial bone products have led to the need 
for new materials; and as such, new and innovative approaches should be 
considered for future cranial bone regenerative biomaterials.   
 Current bone products focus heavily on the use of micron sized 
demineralized bone matrix (DBM) colloids as a tissue matrix/scaffold for the 
promotion of cranial bone formation. Since these materials require bone ingrowth 
from the surrounding peripheral cranial margins, critical cranial defect size limits 
the ability to reconstruct large skull defects.  To address the limited bone 
regeneration associated with demineralized bone techniques, various synthetic 
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and raw materials, such as extracellular matrix (ECM) components, have been 
proposed for tissue regeneration such as hydroxyapatite (Hap), Bioglass, 
hyaluronic acid (HA), DBM, and decellularized cartilage (DCC).(104, 105) Growth 
factors such as bone morphogenetic protein (BMP)-2 and vascular endothelial 
growth factor (VEGF) have shown further promise in bone regeneration, and can 
be used both separately or by dual delivery.(106, 107) The majority of craniofacial 
skeleton forms by intramembranous (IM) ossification; however, leveraging 
endochondral (EC) ossification approaches for regeneration of craniofacial bone 
may provide novel medical treatment avenues.(108) 
 A clinical application that could greatly benefit from a medical product 
exhibiting paste-like rheological properties and bone regenerative potential is the 
surgical management of severe traumatic brain injury (TBI). TBI resulting from a 
severe closed head injury or stroke often causes life-threatening brain 
swelling.(109) Decompressive hemi-craniectomy is a life-saving treatment to 
alleviate brain swelling. In this procedure, approximately half of the patient’s 
calvarial bone is removed allowing the brain to swell and herniate beyond the 
confines of the closed calvarial vault.(110) This skin is draped over the herniating 
brain and the skull is left removed for an average of 80 days  before it is 
restored/replaced once swelling subsides in a second surgical procedure, 
cranioplasty.(111) This surgical procedure gained popularity with its utilization 
and proven beneficial outcomes in the treatment of active duty service who suffer 
severe head trauma in recent military conflicts. These soldiers represent a group 
that has been greatly impacted by TBI, referred to as the “invisible war on the 
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brain”(112) and accounting for 30% of military hospitalizations during modern 
warfare.(113) 
A poorly understood neurologic condition termed “syndrome of the 
trephined” (SoT) often results in TBI patients who undergo hemi-craniectomy. 
SoT is also termed “sinking skin flap syndrome” as a result of the sunken, 
concave appearance of the skull at the sight of hemi-craniectomy that develops 
as TBI patients await cranioplasty.(114, 115) SoT is associated with symptoms 
such as mood changes, fatigue, headaches, dizziness, fine motor dexterity 
problems, and difficulties concentrating.(116) Interestingly, SoT neurologic 
deficits are immediately reversible with a cranioplasty procedure where the 
missing cranial bone is replaced/restored and the underlying sunken cerebral 
tissue is allowed to re-expand within the calvarial vault. The symptoms typically 
return should the cranioplasty reconstruction require future removal such as the 
case of infection. 
Current surgical management of TBI requires a two staged procedure, the 
initial hemi-craniectomy and the reconstructive cranioplasty. They are typically 
performed months apart which delay recovery and rehabilitation and increasing 
cost and risk due to an additional surgery.(117, 118) Research on materials for 
TBI treatment has generally focused on reducing brain swelling(32, 119) or 
blocking tissue regeneration between the dura and periosteum for safer transition 
to cranioplasty.(111) Colloidal gel technology has the potential to provide a single 
surgical treatment for severe TBI cases in which the material is implanted with 
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the initial surgery, remain pliable during brain swelling, and provide a combination 
of materials and growth factors to regenerate bone over time.  
To effectively develop a material capable of providing a single surgery for 
TBI treatment, we must first identify an effective colloidal gel formulation that can 
regenerate bone across a critical size calvarial defect. After identifying a colloidal 
gel that can regenerate bone in a critical size defect, the regeneration time can 
be tuned specifically for treatment of TBI. The objective of this work was to 
evaluate colloidal gels composed of natural materials and growth factors for 
regenerating calvarial bone in a critical size calvarial defect. The use of natural 
materials is our first attempt with this type of formulation, and represents a next 
generation colloidal gel from our previously published work by Wang et al.(103) 
Hap, DBM or DCC nanoparticles were evaluated in physically crosslinked 
colloidal gel formulations with HA to create paste-like materials with desirable 
yield stress for injection in a bone regeneration application. Colloidal gel material 
characterization studies have previously been published by Dennis et al.(37), 
colloidal formulations with desirable mechanical properties were chosen for 
evaluation in the current study. Colloidal gels were loaded with or without BMP-2 
and VEGF to evaluate the extent to which growth factors would facilitate bone 
regeneration. We hypothesized that the colloidal gel formulations would 
regenerate bone at the defect site, and that the addition of DCC particles would 
increase regenerative capabilities.   
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Materials and Methods 
Materials 
Hydroxyapatite (Hap) was purchased in powder form (Davg ≤ 200 nm; 
Sigma-Aldrich, St. Louis, MO). Hyaluronic acid (HA, Mw = 1.01-1.8 Mda) 
(Lifecore Biomedical, Chaska, MN) was purchased as a sodium salt. Human 
demineralized bone matrix (DBM) was purchased from Biomet (Warsaw, IN). 
Human VEGF (Cat# 100-20) and human BMP-2 (Cat# 120-02) were purchased 
from PeproTech (Rocky Hill, NJ). 
 
Preparation of Decellularized Cartilage (DCC) 
Ten porcine knees were purchased from a local abattoir (Bichelmeyer 
Meats, Kansas City, KS). Articulating hyaline cartilage was harvested from 
mixed-breed, mixed-sex hogs 7-8 months of age. Harvested cartilage was coarse 
ground using a cryogenic tissue grinder (BioSpec Products, Bartlesville, OK) and 
packed into dialysis tubing (3500 MWCO) and decellularized using an adapted 
version of our previously established method using osmotic shock, detergent, and 
enzymatic washes.(120-122) Briefly, dialysis packets containing DCC were 
placed in a hypertonic salt solution (HSS) overnight at room temperature under 
agitation (70 rpm). The packets were then subjected to 220 rpm agitation and 
washed in triton X-100 (0.01 v/v) followed by HSS, with DI washes between each 
step, to permeabilize intact cellular membranes. Tissue packets were then 
treated with benzonase enzyme solution (0.0625 KU/mL) at 37°C overnight 
followed by DI washing, and then treated with sodium-lauroylsarcosine (NLS, 1% 
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v/v) overnight to lyse cells and denature proteins. After NLS treatment, the tissue 
was washed in DI water, and then in 40% (v/v) ethanol at 70 rpm. Tissue packets 
were then subjected to organic exchange resins and to remove organic material 
from solution. Tissue packets were then washed in a saline-mannitol solution at 
70 rpm followed by 1 hour of DI washes. The tissue was then removed from the 
dialysis packets and frozen. 
After the decellularization process, DCC particles were lyophilized and 
cryoground with a freezer-mill (SPEX, SamplePrep, Metuchen, NJ). Cryoground 
DCC was then sieved (Spectra/Mesh Woven Filters, Spectrum Laboratories, Inc., 
Rancho Dominguez, CA) (Davg ≤ 200 nm) and stored at -20 ºC for later use. 
Decellularization was confirmed by PicoGreen (Thermo Fisher Scientific, 
Waltham, MA, P7589) assay to determine DNA content. The particle size ranges 
of DCC and Hap were confirmed using dynamic light scattering (Brookhaven, 
ZetaPALS) as previously described.(34)  
 
Preparation of Colloidal Gels 
 Colloidal gels were prepared as previously described.(34) Briefly, 20 mg 
of HA, 800 mg of Hap, and 150 mg of ECM (DCC or DBM) materials were 
weighed dry and combined. Dry combinations were dispersed in 1 mL of 
phosphate buffered saline (PBS, Sigma-Aldrich, P3813) solution. Dry powder 
formulations were sterilized using ethylene oxide gas prior to use in vivo. PBS 
and growth factors were mixed together (25 µg/mL) in select groups before 
dispersion of dry powder combinations. Samples were allowed to reach ambient 
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conditions for 2 hours before implanting. Formulations are reported as material 
components with the addition of growth factors in parentheses [e.g. HA-Hap 
(VEGF)]. 
 
Environmental Scanning Electron Microscopy (ESEM) 
 Colloidal gels were imaged using an FEI Quanta 200 scanning electron 
microscope (FEI Company, Hillsboro, OR) with a tungsten filament electron 
source. The gaseous secondary electron detector (GSED) was used in 
environmental mode. Samples were imaged at a magnification of approximately 
500x, and an accelerating voltage of 15 kV.   
 
Rheological Testing 
 Colloidal gel rheological properties were mapped using a controlled stress 
rheometer (TA-Instruments, AR2000). All measurements were performed at a 
gap distance of 500 μm using a 20 mm diameter roughened stainless steel plate 
geometry. Samples were tested at 37 °C.  Initially, an oscillatory stress sweep 
from 1-10,000 Pa was performed at a constant frequency of 1 Hz to determine 
the linear viscoelastic (LVE) region for the colloidal formulations. The yield stress 
was defined as the oscillatory stress corresponding to a 15% departure of the 
storage modulus (G’) from the LVE region.  
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Animal Model and Surgical Method 
Mixed sex SAS Sprague Dawley rats were raised in house to an age of 7-
10 weeks and randomly assigned to treatment groups prior to surgery. Animal 
experiments were approved by the Institutional Animal Care and Use Committee 
of the University of Kansas Medical Center (protocol #2015-2303). A posterior 
incision along the periphery of the skull was created to peel back and suture the 
skin and periosteum to the anterior portion of the skull. A single critical size 7.5 
mm defect was created on the center of the calvarial bone using a cylindrical drill. 
The calvarial disk was carefully removed leaving the dura matter intact. After 
creation of the defect, approximately 50 μL of material was used to fill the site via 
syringe (Fig. 3.1A). The skin and periosteum were then draped over the defect 
site and sutured in place to hold the material during the healing process. The 
sham group received the same surgical procedure without the addition of any 
further treatment. Repaired tissue was harvested at 8 weeks’ post-implantation 
and analyzed. A sample size of 5 rats was used in BMP-2 containing groups, and 
a sample size of 4 rats was used in all other groups.  
 
Micro-computed Tomography (μCT) 
Micro-computed tomography analysis was performed on explanted rat 
calvarial sections to visualize and quantify new bone formation. An Xradia 
MicroXCT-400 system was used with a 50 kV X-ray source at 7.9 W. μCT images 
were reconstructed to generate 3D models for analysis of new bone formation. 
Avizo-Fire computational software (FEI Company) was used to generate 3D 
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images and quantify volumes. New bone was confirmed using pre-existing 
calvarial bone as the threshold, separating original Hap from new bone formed. 
Hap nanoparticles were partitioned from bone on the basis that any material 
above the bone threshold must be original Hap. Quantified new bone volume is 
expressed as a total (mm3) within the 7.5 mm diameter defect site.  
 
Histology and Immunohistochemistry 
  Harvested calvarial bone samples were fixed in 10% phosphate buffered 
formalin for 48 hours then stored in 70% ethanol for long term. Tissue sections 
were then decalcified using Calrite media (Thermo Fisher Scientific, 22-046-339) 
for 3 weeks before dehydrating in a grade series of ethanol to xylenes, and then 
embedded in paraffin wax. Sections of 5 μm were obtained using a microtome 
(Thermo Fisher Scientific, HM 355S) and affixed to microscope slides. Before 
staining, tissue sections were dewaxed in xylene and rehydrated in graded (i.e., 
100 to 70%) ethanol followed by deionized water. Slides were stained with 
hematoxylin and eosin (H&E) (Abcam, Cambridge, UK, H-3404) for cell infiltration 
and new bone formation. 
Immunohistochemistry was employed to visualize the distribution of 
collagen I (Novus Biological, Littleton, CO, NB600-408, 10 μg/mL), collagen II 
(Novus Biological, NBP2-33343, 5 μg/mL), osteocalcin (Abcam, ab93876, 5 
μg/mL), and α-smooth muscle actin (Abcam, ab5694, 10 μg/mL). Briefly, tissue 
sections were dewaxed in xylenes and rehydrated in a graded series of ethanol 
(100-70%) to DI water. Antigen retrieval was performed enzymatically with 
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proteinase K (Abcam, ab64220, 20 μg/mL) for 15 minutes at 37 °C. Following 
enzymatic retrieval, sections were blocked with 0.3% hydrogen peroxide (Abcam, 
ab94666) for 10 minutes, 10% normal horse serum (Vector Labs, Burlingame, 
CA, PK-6200) for 20 minutes, 5 % bovine serum albumin (Sigma, A9647) for 20 
minutes, and avidin/biotin blocking (Vector Labs, SP-2001) for 15 minutes each. 
Sections were incubated in one of the aforementioned primary antibodies for 1 
hour. Post-primary antibody incubation, sections were washed in PBS with 
Tween-20 (Sigma-Aldrich, P3563) solution for 5 minutes between each step. 
Sections were then incubated with biotinylated horse anti-mouse/rabbit IgG 
(Vector Labs, PK-6200) for 30 minutes. Sections were then incubated with 
VECTASTAIN Elite ABC solution (Vector Labs, PK-6200) for 30 minutes, before 
being developed using DAB (Vector Labs, SK-4100) for 2 minutes. DAB 
enhancing solution (Vector Labs, H-2200) was used for 10 seconds before 
counter-staining with hematoxylin QS (Vector Labs, H-3404) for 1 minute. Bluing 
solution (Thermo Fisher Scientific, 7301) was used for 3 minutes. Finally, 
sections were dehydrated in a grade series of ethanol (95-100%) to xylenes 
before mounting. Negative controls for each immunohistochemical staining batch 
were included.  
 
Statistical Methods 
GraphPad Prism (Graphpad Software Inc, La Jolla, CA) statistical software 
was used to conduct all statistical analyses. Groups were analyzed using a one-
way analysis of variance with groups of factors. Dunnett’s test was used to 
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compare groups to the sham control group. Tukey’s HSD test was used for 
comparing between groups in the rheological analysis. Results were considered 
significant at a level of p < 0.05. Results are reported as the mean ± standard 
deviation. 
 
Results 
Rheological Analysis 
Figure 3.1B shows colloidal material groups being shaped, and ESEM 
images of the gel microstructure. Colloidal material shaping demonstrated that all 
formulations exhibited some degree of yield stress. Representative rheometer 
traces for each colloidal formulation have been provided (Fig. 3.2A-C). The yield 
stress of the HA-Hap-DBM was 4.6 times higher than the HA-Hap formulation (p 
< 0.01) (Fig. 3.2D). Post-hoc analysis (Tukey’s HSD) showed no statistically 
significant difference between HA-Hap and HA-Hap-DCC, or between HA-Hap-
DBM and HA-Hap-DCC formulations.  
 
Microcomputed Tomography (μCT) Analysis 
The HA-Hap (BMP-2) and HA-Hap-DCC groups had 89 and 82% higher 
regenerated bone volume compared to the sham, respectively (Fig. 3.3A, p < 
0.01).  Peripheral bone growth was noted in all groups, and large peripheral bone 
growth into the defect site in the HA-Hap-DCC group without the addition of 
growth factors (Fig. 3.3B). Large bone island formation was noted in the sham 
and VEGF-containing groups, excluding the group containing DCC. Bone islands 
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observed in all groups were very thin compared to the native bone, and did not 
contribute significantly to regenerated bone volume.  
 
Histological Analysis 
A distinctive soft tissue formation spanning the defect site was observed 
in all colloidal gel formulations (Fig. 3.4). The presence of conglomerated colloidal 
particles was observed in all groups. Bone at the defect periphery was noted in 
all groups with new bone forming toward the dural side of the defect. The H&E 
stain confirmed the differences in new bone formation versus original colloidal 
particles identified from the μCT analysis. Histological analysis of all samples 
showed general trends of bone formation encapsulating conglomerated colloidal 
particles in HA-Hap groups with and without addition of growth factors. VEGF 
containing groups tended to have thicker soft tissue formation spanning the 
defect site compared to groups without the addition of growth factors and the 
sham. The HA-Hap-DCC group and the BMP-2 groups had more peripheral bone 
growth into the defect site compared to the sham and VEGF-containing groups.  
 
Immunohistochemical (IHC) Analysis 
Visual results of all samples stained for COL1 show substantial deposition 
of COL1 in the tissue spanning the defect site using peripheral bone for reference 
(Fig. 3.5). COL2 deposition in all groups was near non-existent in the tissue 
spanning the defect site, except for DCC groups with addition of growth factors, 
with the DCC (BMP-2) group in particular showing more regions of collagen II 
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than the DCC (VEGF) group. COL2 deposition in groups containing DCC and 
growth factors resulted in positive staining tissue pockets within the defect site; 
however, this was not seen in DCC samples without growth factors. OCN staining 
was similar to COL1 staining in that all groups showed positive antibody staining 
throughout the defect site using the peripheral bone as a reference. αSMA 
staining was positive only in the soft tissue spanning the defect site and no 
staining in the bone portion as expected.  
 
Discussion 
 The current study was the first to use naturally derived decellularized 
cartilage extracellular matrix for regeneration of calvarial bone.(108) Colloidal 
gels formulated of naturally derived ECM materials were evaluated with and 
without growth factors to determine osteogenic potential in vivo. The focus of this 
work in developing colloidal gels with physical crosslinking properties for ease of 
placement and pliability during the healing process is ideally positioned for the 
treatment of TBI after hemi-craniectomy.(34, 35) The proposed work is one of the 
few to propose a material capable of providing a single-surgical method for 
severe TBI treatment, eliminating the need for a second surgery to reclose the 
cranial vault.(123) A single-surgical intervention for TBI has great implications for 
increasing the quality of life for the people suffering from this issue, and 
decreased time for rehabilitation. In developing these colloidal materials, our 
team has proposed the use of nanoparticle-size DBM and DCC as natural 
materials for the promotion of new bone growth.  
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 Colloidal gels exhibiting a yield stress sufficient to create a paste-like 
consistency may have great clinical relevance for material placement and 
retention. Colloidal gels rely on physical interactions and the presence of a 
suitable yield stress in lieu of covalent crosslinking for material retention. The 
formulations presented in the current study were all capable of forming a paste-
like material, and the addition of ECM materials further increased the yield stress 
observed. ESEM images of the gel microstructure indicated that the addition of 
ECM particles reduced cavitation, contributing to the mechanical stability. An 
increased yield stress in colloidal gels has implications for the improvement of 
mechanical performance in surgical placement and retention in the defect 
site.(35) Although rheological testing confirmed the existence of a noticeable 
yield stress in all formulations, challenges with material retention were observed 
in the current study. In all cases, the majority of migrated material had moved 
anteriorly, possibly due to the normal head grooming motion of rats. Alternatively, 
the migration of Hap particles can possibly be attributed to material disintegration 
due to the lack of gel crosslinking after placement. The post-μCT analysis allowed 
for the ability to better assess regenerative capabilities by quantifying the volume 
of bone excluding the colloidal material, while subsequently visualizing the two. 
Other groups have previously used similar techniques for eliminating the 
quantification of non-bone material;(124) however, it is not uncommon to report 
regenerated new bone volume including the added material.(3) The result of the 
DCC material group without growth factors supports the idea that cartilage can 
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be used as a raw material for use in a paste-like application for calvarial bone 
regeneration.  
 Aggregation of Hap particles was noted in all samples analyzed, 
suggesting interaction between Hap nanoparticles to form larger clusters. Bone 
growth around the Hap clusters was visualized by H&E stain, supporting the 
osteoconductive properties of Hap. Possible osteoinductive potential was 
observed in the form of new bone islands throughout the defect site without the 
presence of Hap particles; however, bone island formation was also noted in the 
sham group. In all samples, a noticeable tissue had formed throughout the defect 
site. Small pockets of positive COL2 staining was noted in the DCC group 
containing BMP-2, leading to the suggestion that growth factor addition had a 
negative role on cell differentiation in the presence of the material DCC. The 
result may potentially be attributed to competing effects of DCC and BMP-2, or a 
synergistic effect of chondrogenesis rather than osteogenesis leading to delayed 
bone regeneration. COL2 deposition was not observed in the group containing 
DCC without growth factors, suggesting that including DCC may have provided 
osteoinductive potential. Consistent positive staining in all groups for COL1 and 
OCN can most likely be attributed to the common material HA-Hap in all groups. 
Additionally, results of αSMA staining showed a positive response in the soft 
tissue portion of the defect site; however, increased blood vessel formation was 
not observed in VEGF treated groups. Addition of BMP-2 did not produce the 
bone regeneration that had been previously observed in similar studies in rat 
calvarial defects. Cowan et al.(125) observed a significant increase in bone 
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formation with the addition of 30 µg/mL of BMP-2 (0.59 µg total); however, this 
was not observed in the current study using 25 µg/mL of BMP-2 (1.25 µg total). 
The differences observed emphasize the value of future growth factor dose 
response studies. The low amount of new bone regeneration in growth factor-
containing groups could possibly be due to a fast release from the defect site, 
causing a low response to available stem cells. Future studies including growth 
factors will include a controlled release mechanism for optimal delivery, and 
characterizing growth factor release in-vitro, as the release profile would have 
been of great value in the current study.  
 The addition of natural materials, i.e., DBM or DCC, had unexpected 
results in terms of bone regeneration potential. On average, the addition of DBM 
did not increase the regenerative potential compared to HA-Hap hydrogels, 
whereas addition of DCC had produced greater bone regeneration on average 
compared to DBM groups. DCC samples without growth factors were observed 
to have large amounts of peripheral bone growth, suggesting potential for DCC 
in calvarial bone regenerative approaches. Regenerated bone volumes of all 
groups tested in the current study were within the range of previously published 
studies in the area, and on average the HA-Hap (BMP-2) and HA-Hap-DCC 
group had more regenerated bone volume.(124, 126) Other groups studying the 
use of cartilage ECM for bone regeneration observed similar findings compared 
to the current study. In a study by Visser et al.(127) using decellularized cartilage 
ECM particles embedded in gelatin methacrylamide hydrogels found mineralized 
bone surrounding hypertrophic cartilage. Similarly, Gawlitta et al.(128) found that 
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bone formation was greatly enhanced by the presence of mesenchymal stem 
cells in decellularized cartilage ECM scaffolds. The collective results from the 
studies previously mentioned and the current study further support the use of 
DCC in bone regeneration applications. Caution should be taken in comparing 
the results of the current study due to the randomized sex study design. The 
National Institute of Health (NIH) notice (NOT-OD-102) “Consideration of Sex as 
a Biological Variable in NIH-funded Research” has identified an over-reliance on 
male animals and cells in research. The random use of both sexes in the current 
study attempts to follow NIH guidelines to eliminate sex as a variable.  
 Poor retention of growth factors and colloidal materials in the defect site 
was observed in the current study. Retention issues may be fixed by 
implementing a covalent crosslinking mechanism after material placement. A 
tunable crosslinking mechanism would effectively provide material stiffness and 
allow for recovery after non-plastic deformation. The crosslinking can be tuned 
accordingly to create hydrogels that remain pliable enough for application in the 
treatment of TBI.  In future studies, colloidal materials encapsulated in covalently 
crosslinked hydrogels will be explored for application to craniofacial bone 
regeneration.  
 
Conclusion 
 Colloidal gels composed of polymers and tissue particles represent a 
promising material for bone regenerative approaches, specifically in their ability 
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to exhibit paste-like properties for surgical placement. The study evaluated 
bone regeneration of critical size (7.5 mm) rat calvarial defects using colloidal 
gels comprised of hyaluronic acid, hydroxyapatite, and tissue particles (DCC or 
DBM) with and without the addition of growth factors (BMP-2 and/or VEGF). All 
colloidal formulations exhibited suitable yield stress for material placement, and 
an increased yield stress performance with the addition of DBM or DCC 
particles. Significant bone volume regeneration was observed in the HA-Hap 
(BMP-2) and HA-Hap-DCC group compared to the sham defect after 8 weeks. 
The results suggest that the material DCC has osteogenic potential for bone 
regeneration applications. Colloidal gels incorporating natural ECM materials 
have promise for calvarial bone regeneration applications. 
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Chapter 4: Decellularized Cartilage-Based Hydrogel 
Encapsulating Osteoconductive Particles for Calvarial Bone 
Regeneration3 
 
Abstract 
In the treatment of severe traumatic brain injury (TBI), decompressive 
craniectomy is commonly used to remove a large portion of calvarial bone to allow 
unimpeded brain swelling. Hydrogels have the potential to revolutionize TBI 
treatment by permitting a single-surgical intervention, remaining pliable during 
brain swelling, and tuned to regenerate bone after swelling has subsided. With 
this motivation, our goal is to present a pliable material capable of regenerating 
calvarial bone across a critical size defect. We therefore proposed the use of a 
methacrylated solubilized decellularized cartilage (MeSDCC) hydrogel 
encapsulating synthetic osteogenic particles of hydroxyapatite nanofibers 
(HAPnf), bioglass microparticles (BG), or added rat bone marrow-derived 
mesenchymal stem cells (rMSCs) for bone regeneration in critical-size rat 
calvarial defects. Fibrin hydrogels were employed as a control material for the 
study. MeSDCC hydrogels exhibited sufficient rheological performance for 
material placement before crosslinking (𝜏𝑦 > 500 Pa), and sufficient compressive 
moduli post-crosslinking (E > 150 kPa). Bone regeneration was minimal in both 
   
3Submitted as: Townsend JM, Zabel TA, Feng Y, Wang J, Andrews BT, Nudo RJ, Berkland 
CJ, Detamore MS. Decellularized Cartilage-Based Hydrogel Encapsulating Osteoconductive 
Particles for Calvarial Bone Regeneration. Biomedical Materials, 2017. 
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MeSDCC and fibrin groups, even with colloidal materials or added rMSCs. 
Minimal bone regeneration in the MeSDCC test groups may potentially be 
attributed to cartilage solubilization after decellularization, in which material 
signals may have degraded from enzymatic treatment. Looking to the future, an 
improvement in the bioactivity of the material will be crucial to the success of 
bone regeneration strategies for TBI treatment.  
 
Introduction 
 Traumatic brain injury (TBI) is characterized by severe brain swelling 
commonly resulting from motor vehicle accidents, assaults, and stroke. Active 
duty military service members are especially vulnerable to this condition, as an 
estimated 22% of wounded soldiers evacuated from conflict zones have severe 
TBI.(113) The brain swelling that results from TBI can be life-threatening as the 
brain lies within a closed cranial vault incapable of expansion to mitigate rising 
intracranial pressures.  Currently, severe TBI is treated by a two-stage surgical 
intervention.  In the first stage, a large portion of calvarial bone is removed in a 
procedure termed decompressive craniectomy.(129) Decompressive 
craniectomy allows the brain to swell beyond the cranial vault and reduces 
dangerous intracranial pressure.(117) After brain swelling has sufficiently 
decreased, typically weeks to months later, a second procedure termed 
cranioplasty is performed to restore the skull anatomy and reclose the cranial 
vault.(111) Disadvantages of the current two-stage TBI surgical intervention are 
that it prolongs neurorehabilitation and recovery, increases medical costs, and is 
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associated with adverse neurologic symptoms termed syndrome of the 
trephined.(130) Syndrome of the trephined, also known as sinking skin flap 
syndrome, is manifested by symptoms such as headaches, unsteadiness, a 
feeling of apprehension, difficulties concentrating, and fine-motor dexterity 
concerns. Interestingly, these often debilitating neurologic symptoms of 
syndrome of the trephined are immediately reversible with a cranioplasty 
procedure to restore the cranial vault anatomy.(114, 116) Previous attempts to 
combine the two-stage TBI treatment into a single surgery have resulted in 
extremely high complication rates due to the inability of materials to expand as 
initial brain swelling occurs.(123) Current commercial bone products for 
cranioplasty have been unsuccessful in meeting the demand required for TBI 
treatment, in either single or two-stage surgical approaches. 
 Current materials used in commercially available cranioplasty products for 
bone repair include allogenic bone, synthetic calcium-apatite, and custom 
polymer/metallic implants.(131) Products that utilize allogenic bone, such as 
DBX® (MTF/Synthes) and AlloFuse® (AlloSource), have reported advantages of 
favorable material integration and low rejection; however, issues with batch 
variability have been noted as potential limitations of using human bone 
matrix.(16, 132) Current allogenic bone products have limited use in cranioplasty 
procedures with large cranial defects, termed critical size defects, resulting in 
reasonable bone regeneration at the defect periphery but minimal regeneration 
centrally. Synthetic calcium-apatite products, such as NovaBone Putty® 
(NovaBone Products), which utilize synthetic processes for high-reproducibility, 
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are reported to have acceptable osteoconductive material properties.(133) 
Similar issues using synthetic apatite approaches compared to allogenic bone 
products persist with regard to limited bone regeneration across large defect 
sizes. Cranioplasty approaches utilizing custom-made implants generated based 
on computed-tomography have gained popularity within the medical community 
for their patient-specificity.(131, 134) Although custom-made implants are 
attractive for repairing the cranial vault, they lack in their ability to regenerate 
calvarial bone, and cannot be implemented in a single surgery for TBI cases due 
to issues with material flexibility during brain swelling. Beyond commercial 
products, research avenues for TBI-related issues have generally focused on 
easing transition between decompressive craniectomy and cranioplasty,(111) or 
focused on intracerebral regenerative medicine.(119, 135-138) Major gaps in 
current knowledge exist regarding materials capable of regenerating bone in 
critical size defects, and in materials that can be implemented in a single surgery 
for treatment of TBI while avoiding syndrome of the trephined. The first step in 
meeting the overall goal of developing a single surgical intervention for the 
treatment of TBI is to first identify a pliable material capable of regenerating 
calvarial bone across a critical size defect. Once the first step has been achieved, 
the regenerative medicine community can focus on translating materials for 
treatment of TBI. Hydrogels are a promising class of materials for calvarial bone 
regeneration and future TBI application, offering the capability for in situ 
placement, allowing for application to any shape or size of defect, 
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photocrosslinking for user-defined material activation, and modulation of stiffness 
for material elasticity during brain swelling.(20)  
 The objective of the current study was to evaluate the use of a 
methacrylated solubilized decellularized cartilage (MeSDCC) hydrogel 
encapsulating synthetic osteogenic particles of hydroxyapatite nanofibers 
(HAPnf), bioglass microparticles (BG), or added rat bone marrow-derived 
mesenchymal stem cells (rMSCs) for bone regeneration in critical size rat 
calvarial defects. Fibrin hydrogels were used as a control material for the study. 
The combinational use of photo-crosslinking cartilage-based hydrogel matrix in 
combination with synthetic particles represents a next-generation approach from 
our previously published work in the area.(36) The choice of cartilage as a 
material to facilitate bone regeneration is inspired by the process of endochondral 
ossification during fracture healing. In a previous publication from our group, the 
three phases of endochondral ossification: inflammatory, reparative, and 
remodeling, were reviewed in detail.(108) During the reparative phase, a fibrous 
and cartilaginous tissue forms spanning the defect. The use of cartilage in the 
current study attempted to circumvent the initial phases of the endochondral 
ossification process to accelerate the formation of bone by delivering a similar 
tissue. Although the calvarium forms from intramembranous ossification, 
endochondral ossification can be leveraged as an attractive route to increase 
bone regeneration. Previous in vitro studies conducted by our group using rMSCs 
encapsulated in cartilage-based hydrogels demonstrated an initial increase of 
collagen I gene expression.(2) The combination of in vitro data regarding 
 
 
60 
 
cartilage-based hydrogels and in vivo results using cartilage as a biomaterial for 
bone regeneration inspired further evaluation of cartilage in calvarial bone 
regeneration. The addition of synthetic particles to the hydrogel matrix serves a 
dual purpose, to create a paste-like consistency to facilitate material placement 
by the surgeon, and to aid in bone regeneration by delivering osteogenic 
materials. We hypothesized that decellularized cartilage-based hydrogel would 
facilitate bone regeneration, and that the addition of synthetic osteogenic 
particles would further improve overall bone regeneration.  
 
Materials and Methods 
Preparation of Decellularized Cartilage (DCC) 
 Ten porcine knees were purchased from a local abattoir (Bichelmeyer 
Meats, Kansas City, KS). Hyaline cartilage was harvested from castrated male 
Berkshire hogs, 7-8 months of age and 120 kg in weight. The cartilage processing 
and decellularization protocol is described in our previous publication.(48) Briefly, 
harvested hyaline cartilage was rinsed, strained, then coarse-ground using a 
cryogenic tissue grinder (BioSpec Products, Bartlesville, OK). The coarse-ground 
cartilage was then packed into dialysis tubing (MWCO 3500) packets. 
Decellularization was achieved through a series of solution exchanges of osmotic 
shock, detergent, and enzymatic washes as described in our previously 
established protocols.(120-122) Dialysis packets containing cryoground cartilage 
were placed in hypertonic salt solution (HSS) at room temperature under agitation 
(70 rpm) overnight. Dialysis packets were then washed in triton X-100 (0.01 v/v) 
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at 220 rpm, followed by HSS, with DI washes between each step to permeabilize 
cellular membranes. Dialysis packets were then treated with benzonase enzyme 
solution (0.0625 KU/mL) at 37°C overnight followed by DI washing before 
treatment with sodium-lauroylsarcosine (NLS, 1% v/v) overnight for cell lysis and 
protein denaturation. Afterwards, dialysis packets were washed with DI water 
then 40% (v/v) ethanol at 70 rpm. Dialysis packets were then soaked in DI water 
with organic exchange resins to remove organic material from solution. Dialysis 
packets were then subjected to a saline-mannitol solution followed by DI washes. 
The tissue was then removed from the tissue packets, frozen, and lyophilized. 
After decellularization, DCC particles were cryoground using a freezer-mill (SPEX 
6775, SamplePrep, Metuchen, NJ). Cryoground DCC was stored at -20°C for 
later use. The decellularization process was confirmed by PicoGreen assay 
(Thermo Fisher Scientific, Waltham, MA, P7589). 
 
Synthesis of Methacrylated Solubilized Decellularized Cartilage (MeSDCC) 
 Solubilization and methacrylation of DCC was achieved using a protocol 
from our previously reported methods.(89) Briefly, solubilized DCC (sDCC) was 
created by mixing DCC powder in 0.1 M HCL at a concentration of 10 g/L. Pepsin 
(Cat# P7000, Sigma-Aldrich, St. Louis, MO) was then added to the DCC-HCL 
solution at a concentration of 1 g/L and stirred at 200 rpm for 48 hours at room 
temperature. The solution was then brought to physiological pH by adding 1 M 
NaOH. The solubilized DCC was then centrifuged at 7,000 x g for 5 min to pellet 
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any unsolubilized DCC particles. The supernatant was then retained, frozen, and 
lyophilized for later use as sDCC. 
 MeSDCC was synthesized by first dissolving sDCC in a 1:1 water:acetone 
mixture at a concentration of 10 g/L. sDCC was then reacted with 20-fold molar 
excess of glycidyl methacrylate (Cat# 779342, Sigma-Aldrich) in the presence of 
62rimethylamine (Cat# T0886, Sigma-Aldrich) and tetrabutylammonium bromide 
(Cat# 426288, Sigma-Aldrich). The reaction was then stirred at 200 rpm for 6 
days at room temperature. Afterward, MeSDCC was precipitated in an excess of 
acetone, then centrifuged at 3,000 x g for 3 min to pellet the MeSDCC. Pelleted 
MeSDCC was then dialyzed in DI water for 48 hours before freezing and 
lyophilizing for later use. The molar excess of glycidyl methacrylate to sDCC was 
approximated based on reacting one glycidyl methacrylate group to every 
monomer present in solution, assuming all monomers present were hyaluronic 
acid.  
 
Rat Bone Marrow Harvest and Culture 
 rMSCs were harvested from the femurs of a male Sprague-Dawley rat 
(200-250 g) following an approved IACUC protocol at the University of Kansas 
(AUS #175-08). The rMSCs were cultured for 1 week in minimum essential 
medium-α (MEM-α, Cat# 12561072, Thermo Fisher Scientific, Waltham, MA) with 
10% fetal bovine serum (FBS, Cat# 16000044, Thermo Fisher Scientific) and 1% 
antibiotic-antimyotic (Cat# 15240-062, Thermo Fisher Scientific) to ensure no 
contamination after harvest. After 1 week of culture, the antibiotic-antimyotic was 
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substituted for 1% penicillin/streptomycin (Cat# 15140-122, Thermo Fisher 
Scientific). Medium was exchanged every other day and cells were cultured until 
passage 3 before encapsulating the cells in material.  
 
Hydrogel Preparation 
 MeSDCC hydrogels were prepared as previously described.(36) Briefly, 
100 mg of MeSDCC and 100 mg of particles were weighed dry and combined. 
Hydroxyapatite nanofibers (HAPnf) were bestowed from Nanova Biomaterials, 
Inc. (Columbia, MO), and 1393-B3 bioglass (BG) microparticles (Davg = 75 – 125 
µm) were gifted from MO-SCI, Corp. (Rolla, MO). 1393-B3 BG is a borate glass 
containing 53% B2 O3 (wt/wt). Dry material combinations were sterilized using 
ethylene oxide gas (AN74i, Anderson Anprolene, Haw River, NC) prior to use in 
vivo. Dry combinations were dispersed in 1 mL of phosphate buffered saline 
(PBS, Cat# P3813, Sigma-Aldrich) solution containing 0.05% 2-Hydroxy-4′-(2-
hydroxyethoxy)-2-methylpropiophenone (I2959, Cat# 410896, Sigma-Aldrich) as 
the photo-initiator. The MeSDCC group with added rMSCs was made by making 
a 2x concentration of MeSDCC in PBS containing 0.1% I2959, and an equal 
volume of medium with cells was added to the 2x material and mixed, bringing 
the final rMSC concentration to 106 cells/mL. MeSDCC groups were loaded into 
1 mL sterile syringes for later use.  
 Fibrin hydrogels were created using a dual syringe (2x2 mL, 1:1 ratio) and 
mixing tip (3x6 mm) purchased from Merlin Packaging Technologies (Gahanna, 
OH). Due to the quick setting time of enzymatically crosslinked fibrin hydrogels, 
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the dual syringe system was necessary to stop the material from prematurely 
crosslinking. In the first compartment, Human fibrinogen 1 (Cat# Fib1, Enzyme 
Research Labs, South Bend, IN) was dissolved in pooled normal plasma (Cat# 
0010-5, George King Biomedical, Overland Park, KS) at a concentration of 10% 
(w/v). The second compartment contained a solution of 20 units/mL of human α-
thrombin (Cat# HT1002A, Enzyme Research Labs) dissolved in a 40 mM CaCl2 
solution. After mixing, the final concentration was 5% fibrinogen, 10 units/mL of 
human α-thrombin, 20 mM CaCl2, dissolved in a 50% (v/v) solution of normal 
human plasma. Fibrin groups with particles (HAPnf or BG) were added equally 
to both syringes of the dual mixing syringe at a concentration of 10% (w/v). The 
fibrin group with cells was achieved by mixing concentrated cells and medium 
with 20 units/mL human α-thrombin and 40 mM CaCl2 in the dual syringe. The 
final concentration of components was the same as the other groups, with a final 
cell concentration of 106 cells/mL.   
 
Rheological Testing of Hydrogel Precursor Solution 
 Hydrogel precursor solution yield stress was determined using an AR2000 
controlled stress rheometer (TA-Instruments, New Castle, DE). Measurements 
were performed using a gap distance of 500 µm using a 20-mm diameter 
crosshatched stainless steel plate geometry and a crosshatched Peltier plate 
cover at 37°C (n = 5). Precursor yield stress was measured over an oscillatory 
shear stress sweep from 1-3000 Pa. The yield stress of each material was 
determined by the cross-over point of the storage (G’) and loss modulus (G”). 
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Hydrogel precursor solutions were prepared as previously described, with the 
exception that the fibrin groups were prepared without the enzymatic crosslinker 
α-thrombin.  
 
Mechanical Testing of Crosslinked Hydrogel 
 The crosslinked hydrogel compressive modulus (n = 5) was determined 
using an RSA III dynamic mechanical analyzer (TA-Instruments). Hydrogels for 
mechanical testing were prepared as previously described.(35) Briefly, hydrogel 
precursor solution was loaded into a 2 mm thick Teflon mold sandwiched 
between glass microscope slides. MeSDCC hydrogels were crosslinked with a 
312 nm UV-light at 9 mW/cm2 for 10 min (EB-160C, Spectroline, Westbury, NY). 
Fibrin hydrogels were crosslinked by injecting the two precursor solutions into the 
mold space using the dual syringe with mixing tip, the fibrin mixture was allowed 
to set for 5 min. After crosslinking, circular hydrogels were cut using a sterile 3 
mm biopsy punch. Hydrogels were pre-swollen in PBS for 24 hours before 
mechanical testing. The swollen hydrogel diameter was measured using a stereo 
microscope (20x magnification) and a micrometer, and the hydrogel height was 
measured using the RSA III. Hydrogels were compressed at a constant rate of 
0.005 mm/s until mechanical failure.(139) The compressive modulus was 
calculated from the slope of the linear portion of the stress-strain curve between 
10-20% strain.   
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Animal Model and Surgical Method 
 Animal experiments were approved by the Institutional Animal Care and 
Use Committee of the University of Kansas Medical Center (protocol #2015-
2303). The animal model and surgical method was conducted as previously 
described.(36) Briefly, mixed-sex Sprague-Dawley rats were raised to an age of 
7-10 weeks in-house and randomly assigned to treatment groups (n = 5). An 
incision was created on the posterior periphery of the skull to pull back the skin 
and periosteum exposing the calvarium. A critical-size (7.5 mm diameter) full 
thickness bone defect was created in the center of the calvarium (parietal bone) 
using a dental trephine. The circular piece of calvarial bone was removed, leaving 
the dura mater intact, and approximately 50 L of material was syringed into the 
defect. MeSDCC groups were then crosslinked using a handheld 312 nm UV-
light, and fibrin groups were allowed to enzymatically crosslink for 5 min after 
injection of material. The skin flap was then draped over the defect site and 
sutured to hold the material in place during the recovery period. The sham group, 
which has been republished from our previous study, received the same surgical 
method without the addition of material.(36) The DBX® group received 
approximately 50 L of DBX® Putty. The treated and untreated calvarial bone 
defects were harvested with the surrounding bone at 8 weeks post-implantation.  
 
Micro-computed Tomography (µCT) 
 Micro-computed tomography was performed on harvested rat calvarial 
bone after the 8-week recovery period to quantify new bone. A MicroXCT-400 
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(Carl Zeiss X-ray Microscopy, Pleasanton, CA) system with a 50-kV X-ray source 
at 7.9 W was used. Reconstructed µCT scans were analyzed using Avizo Fire 
computational software (FEI Company, Hillsboro, OR) to quantify new bone 
formation. New bone was confirmed using pre-existing bone as the threshold 
limit. Bone within the original 7.5 mm diameter defect was colored orange to 
indicate new bone formation. Quantified new bone is presented as the total (mm3) 
within the 7.5 mm diameter defect.  
 
Histology and Immunohistochemistry (IHC) 
 Explanted calvarial bone defect samples were fixed in 10% phosphate-
buffered formalin for 48 hours then stored long term in 70% ethanol. Calvarial 
tissue samples were then decalcified in Calrite media (Cat# 22-046-339, Thermo 
Fisher Scientific) for 3 weeks before dehydrating in a grade series of ethanol to 
xylene, then to paraffin wax for embedding. Using a microtome (HM 355S, 
Thermo Fisher Scientific), 5 µm thick sections were taken and affixed to 
microscope slides. Tissue slides were heated to 60°C for 20 min to improve 
adhesion of tissue to slides, then stored long term at -20°C. Before staining, 
tissue slides were dewaxed in xylene then rehydrated in a graded series of 
ethanol (i.e., 100% to 70%) followed by PBS. Slides were stained with 
hematoxylin and eosin (H&E, Cat# H-3404, Abcam, Cambridge, UK) to visualize 
cell infiltration and new bone formation.  
 Immunohistochemistry (IHC) was used to visualize the deposition of 
collagen I (Cat# NB600-408, Novus Biologicals, Littleton, CO) and collagen II 
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(Cat# NBP2-33343, Novus Biologicals) within the defect site. An in-depth protocol 
of the IHC procedure has been previously published.(36) Briefly, after tissue 
dewaxing and rehydrating to PBS with Tween-20 (Cat# P3563, Sigma-Aldrich), 
antigen retrieval was performed using 20 µg/mL proteinase K (Cat# ab64220, 
Abcam) for 15 min at 37°C, then cooled at room temperature for 10 min. Sections 
were then blocked with 0.3% hydrogen peroxide (Cat# ab94666, Abcam) for 10 
min, 10% normal horse serum (Cat# PK-6200, Vector Labs, Burlingame, CA) for 
20 min, 5% bovine serum albumin (Cat# A9647, Sigma-Aldrich) for 20 min, and 
avidin/biotin blocking (Cat# SP-2001, Vector Labs) for 15 min each. Sections 
were then incubated with either 10 µg/mL of collagen I or 5 µg/mL of collagen II 
(100 µL volume) for 1 hour. After incubation of sections with the primary antibody, 
slides were washed between each following step using PBS with Tween-20 for 5 
min. Sections were then incubated with biotinylated horse anti-mouse/rabbit IgG 
(Cat# PK-6200, Vector Labs) for 30 min, VECTASTAIN Elite ABC solution (Cat# 
PK-6200, Vector Labs) for 30 min, DAB solution (Cat# SK-4100, Vector Labs) for 
2 min, DAB-enhancing solution (Cat# H-2200, Vector Labs) for 10 s, 
counterstained using hematoxylin QS (Cat# H-3404, Vector Labs) for 1 min, 
bluing solution (Cat# 7301, Thermo Fisher Scientific) for 3 min, then dehydrated 
in a graded series of ethanol (i.e., 70-100%) to xylene before mounting. Negative 
controls for each IHC batch were included to confirm negligible background 
staining.  
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Statistical Methods 
 Statistical analyses were conducted using the GraphPad Prism (Graphpad 
Software Inc, La Jolla, CA) statistical software. A one-way analysis of variance 
with groups of factors was used to analyze groups. Tukey’s post-hoc test was 
used for comparing between groups. Rheological testing, mechanical testing, and 
µCT had n = 5 samples per group, and data are reported as the mean ± standard 
deviation.  
 
Results 
Rheological Analysis of Hydrogel Precursor 
 Representative rheometer traces are provided for each hydrogel precursor 
solution that exhibited a yield stress (Fig. 4.1A). Fibrin and fibrin-BG did not create 
a noticeable yield stress after being mixed. The yield stress of the MeSDCC-
HAPnf group (1641 Pa) was 3.3 and 4.4 times greater than those of the MeSDCC 
and fibrin-HAPnf group, respectively (Fig. 4.1B, p < 0.0001). The yield stress of 
the MeSDCC-BG group (1456 Pa) was 2.9 and 3.9 times greater than those of 
the MeSDCC and fibrin-HAPnf group, respectively (p < 0.0001). No significant 
difference was observed between MeSDCC and fibrin-HAPnf, or between 
MeSDCC-HAPnf and MeSDCC-BG formulations.  
 
Mechanical Analysis of Crosslinked Hydrogel 
 Representative stress-strain curves are provided for each material 
formulation post-crosslinking (Fig. 4.2A-B). The MeSDCC-HAPnf group (711 
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kPa) had a compressive modulus that was 4, 26.4, 45.7, and 29.4 times greater 
than the compressive moduli of the MeSDCC, fibrin, fibrin-HAPnf, and fibrin-BG 
groups, respectively (Fig. 4.2C, p < 0.01). The MeSDCC-BG group (989 kPa) had 
a compressive modulus 5.5, 36.7, 63.6, and 40.9 times greater than those of the 
MeSDCC, fibrin, fibrin-HAPnf, and fibrin-BG groups, respectively (p < 0.01). No 
other differences in modulus were statistically significant. 
 
Micro-computed Tomography (µCT) Analysis 
 Large bone islands were observed in both the sham and DBX group; 
however, bone islands observed in the sham group were thin and did not 
significantly contribute to overall total regenerated bone volume (Fig. 4.3A). Small 
bone island formation was observed in all samples except the MeSDCC group 
and groups containing HAPnf. Peripheral bone growth was observed in all 
samples. The DBX group (8.94 mm3) had 2.1, 2.7, 2.8, 4.3, 5.5, 3.1, 3.0, 3.1, and 
2.6 times greater bone regeneration compared to the sham, fibrin, fibrin+Cells, 
fibrin-HAPnf, fibrin-BG, MeSDCC, MeSDCC+Cells, MeSDCC-HAPnf, and 
MeSDCC-BG groups, respectively (Fig. 4.3B, p < 0.05). No significant difference 
was observed among any other group.  
 
Histological and Immunohistochemistry (IHC) Analysis 
 Soft tissue formation spanning the defect site was observed in all samples 
(Fig. 4.4). Peripheral bone growth was observed in all samples and tended to 
form toward the dural side of the defect. No differences were noted among the 
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MeSDCC or Fibrin groups with or without the addition of rMSCs. Groups with 
exogenously added cells did not appear to have a higher number of stained nuclei 
within the defect. Groups containing HAPnf had leftover material within the defect 
site after the 8-week recovery period, and in some samples, cells were unable to 
migrate to the center of the material. Leftover MeSDCC hydrogel was observed 
in the MeSDCC-BG group based on collagen II deposition. Leftover BG particles 
were observed in both MeSDCC and Fibrin hydrogels and tended to migrate to 
the periphery of the defect site in all samples.  
 Collagen I staining showed substantial deposition throughout the defect 
site, including the soft tissue portion (Fig. 4.5). Native peripheral bone was used 
as the reference for comparison. In groups containing HAPnf, minimal deposition 
of collagen I was observed toward the center of the defect. Staining for collagen 
II showed almost no collagen II deposition within the defect site, except for the 
MeSDCC-BG group, where small tissue pockets positively staining for collagen 
II deposition were observed. 
 
Discussion 
 The current study was the first to use an in situ crosslinking hydrogel 
comprised of naturally-derived decellularized cartilage-based matrix for calvarial 
bone regeneration in vivo. The use of a cartilage-based hydrogel for bone 
regeneration follows our previous work using micronized decellularized hyaline-
cartilage particles and hydroxyapatite colloidal gels for bone regeneration in 
vivo.(36) In designing hydrogels with potential for TBI treatment in mind, the 
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mechanical performance of the material before and after UV-crosslinking was 
identified as a crucial aspect for clinical translation.(20) All MeSDCC hydrogels 
tested exhibited sufficient yield stress (𝜏𝑦 > 500 Pa) for material placement, and 
addition of HAPnf or BG particles significantly increased the yield stress of the 
material to a range of 1400 to 1600 Pa. For context, the yield stress of 
mayonnaise is approximately 200 Pa, and the yield stress of Play-Doh is 
approximately 3000 Pa.(67) The potential reason that only the fibrin-HAPnf led 
to a detectable yield stress may have been that the fibers would conceivably 
interact more with their surrounding environment than a sphere due to the 
randomized fiber orientation distribution, and a changing microstructure from 
fiber-fiber and fiber-medium interactions.(140) Although the calvarium is a non-
load bearing bone, sufficient material mechanical performance is necessary to 
remain in place during healing, and provide a barrier between the brain and scalp. 
Due to stiffness being an important parameter for material success, the 
compressive modulus of hydrogels was characterized. After crosslinking of the 
hydrogel precursor, MeSDCC hydrogels with colloids had considerably higher 
compressive moduli compared to fibrin groups; however, no significant difference 
was observed among the MeSDCC group and the fibrin groups. The addition of 
colloids in fibrin groups did not increase the compressive modulus as observed 
in the MeSDCC groups. Comparing fibrin and MeSDCC without particles, 
MeSDCC on average had a higher compressive modulus, potentially due to a 
greater crosslinking density. The difference in compressive modulus could be in 
part due to limited initial crosslinking in fibrin groups compared to MeSDCC, and 
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thus the added colloids were not sufficiently encapsulated in the matrix, or that 
the MeSDCC material interacted with the particles to a greater extent. 
Additionally,  Although the compressive modulus of native bone is on the 
magnitude of Gpa, hydrogels do not necessarily need to match the compressive 
modulus of native bone in the calvarium due to the non-load bearing nature.(141) 
The elastic nature of a hydrogel would also be beneficial for future TBI application 
allowing pliability during brain swelling. For these reasons, we have identified a 
minimum compressive modulus of 100 kPa, similar to human skin tissue to 
maintain shape while remaining pliable.(142)  
 In vivo bone tissue formation within the defect for both fibrin and MeSDCC 
groups was minimal. No difference in bone formation was observed among any 
fibrin or MeSDCC formulation. The DBX® group was the only group to outperform 
the sham control in regenerated bone volume, showing increased bone formation 
spanning into the defect. Sham groups had noticeable bone island formation 
covering an ample area; however, the bone formed was especially thin and did 
not contribute significantly to the overall bone volume. Sporadic small bone island 
formation was observed in all groups, with the exception of the HAPnf-containing 
groups. H&E staining revealed a large amount of leftover HAPnfs in both fibrin 
and MeSDCC formulations. The HAPnf appeared to perhaps inhibit cell migration 
toward the center of the material. Cell migration issues with HAPnf were 
especially problematic in combination with MeSDCC, potentially due to the high 
compressive modulus and yield stress of the material during hydrogel 
degradation for cellular infiltration. Collagen I deposition was homogeneous 
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throughout all samples except the HAPnf containing groups, where there was 
minimal positive staining for collagen I in the center of the material, most likely 
due to the lack of cellular infiltration into the material. The only material to have 
leftover hydrogel matrix inside the defect after the 8-week period was the 
MeSDCC-BG group; however, the remaining volume was especially small and 
not apparent in all samples. Collagen II deposition was not detected in all samples 
except for the MeSDCC-BG group, in which the leftover MeSDCC hydrogel 
positively stained for collagen II. One may argue that the incorporation 
enzymatically degradable sequences or a material porogen may enhance 
regenerative capabilities by facilitating cellular infiltration and remodeling. 
However, the observation of remaining MeSDCC in only one group, juxtaposed 
with the limited capacity of regeneration even with rMSCs present, leads to the 
conclusion that the inherent material bioactivity is the primary focus for future 
improvement becomes, with cell infiltration and migration being relegated to a 
secondary issue.  
 Although our group was the first to use naturally derived cartilage for 
calvarial bone regeneration, other groups have studied the use of cartilage matrix 
(naturally derived or tissue engineered) for bone formation. Cunniffe et al.(143) 
studied the use of chondrogenically-primed rMSCs encapsulated in alginate 
hydrogels to partially mimic the endochondral ossification healing process in rat 
critical-size femur and calvarial defects. The rMSC-alginate hydrogels appeared 
to support bone formation at the hydrogel surface, and comparable bone 
regeneration to the current study was observed. In another study from that same 
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group, a decellularized tissue engineered cartilage scaffold was studied for use 
in long bone defect healing.(144) The tissue engineered cartilage scaffold 
promoted more bone regeneration on average compared to the sham group; 
however, a considerable amount of deviation was observed within the group. 
Both studies by Cunniffe et al. illustrated promise for the use of cartilage-derived 
matrix/cells in promoting bone regeneration by recapitulating part of the 
endochondral ossification process. In a study using DCC scaffolds to promote 
endochondral bone formation, collagen I deposition was observed after 22 days 
of subcutaneous implantation in a rat model.(128) Similarly, in another study, 
collagen I deposition and mineralization was observed in gelatin methacrylamide 
hydrogels encapsulating DCC particles after 8 weeks of in vivo rat subcutaneous 
implantation.(145) Both studies supported the use of DCC as a material for bone 
regeneration. In comparing the referred studies to the current study, limited bone 
regeneration with MeSDCC hydrogels in the current study may potentially have 
been attributed to the processing of DCC. The further processing of DCC to 
create MeSDCC may potentially have contributed to a lower bioactivity and 
subsequent lower bone formation. DCC solubilization is speculated to have been 
the major contributing factor in the reduction of material bioactivity, as potential 
signals may have been affected by the process. Reduced bioactivity due to tissue 
decellularization has been previously discussed, in which devitalized cartilage 
(DVC) had greater bioactivity than DCC potentially due to altering matrix 
architecture and a reduction of important growth factors from 
decellularization.(48) DVC is cartilage extracellular matrix that has only 
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undergone physical processing (i.e., granulating) without the additional step of 
chemical decellularization.(7) In another study from our group evaluating 
methacrylated solubilized devitalized cartilage (MeSDVC) loaded with DVC 
particles, increased gene expression was observed in MeSDVC hydrogels with 
DVC particles compared to MeSDVC alone.(2) Therefore, both decellularization 
and solubilization could potentially contribute to lower bioactivity. Future studies 
using cartilage will focus on minimizing the processing of cartilage to retain 
material activity, in which the use of DVC may be of interest for enhancing 
endochondral bone formation. Further research is necessary to fully characterize 
the use of cartilage in bone regeneration in general, and in calvarial defect 
regeneration in particular.  
 
Conclusion 
 MeSDCC hydrogels composed entirely of naturally-derived DCC 
demonstrated desirable handling properties in the pre-crosslinked form, and 
appropriate mechanical performance post-crosslinking for a cranioplasty 
application. The addition of synthetic particles (HAPnf or BG) increased the 
mechanical stiffness of MeSDCC hydrogels several fold, approaching the 1 Mpa 
mark in compressive modulus, which may be desirable in a TBI application. In 
vivo testing in an 8-week rat calvarial defect model demonstrated minimal bone 
formation in both MeSDCC and fibrin groups containing osteoconductive 
particles. Encapsulated rMSCs did not appear to influence bone formation in 
either fibrin or MeSDCC hydrogels, and significant bone formation was only 
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observed in the DBX® group, suggesting that material bioactivity may be the 
governing limitation beyond cell infiltration.  Minimal bone formation using 
MeSDCC compared to other published studies potentially suggests that DCC 
solubilization may have potentially reduced material activity in this application. 
Further research is necessary to determine the full capacity of cartilage (DCC 
and DVC) as a material to promote bone regeneration.  
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Chapter 5: Superior Calvarial Bone Regeneration with 
Pentenoate-Functionalized Hyaluronic Acid Hydrogels with 
Devitalized Tendon Particles4 
 
Abstract 
 Traumatic brain injury (TBI) is a life-threatening condition defined by 
internal brain herniation. Severe TBI is commonly treated by a two-stage surgical 
intervention, where decompressive craniectomy is first conducted to remove a 
large portion of calvarial bone and allow unimpeded brain swelling. In the second 
surgery, spaced weeks to months after the first, cranioplasty is performed to 
restore the cranial bone. Hydrogels with paste-like precursor solutions for surgical 
placement may potentially revolutionize TBI treatment by permitting a single-
stage surgical intervention, capable of being implanted with the initial surgery, 
remaining pliable during brain swelling, and tuned to regenerate calvarial bone 
after brain swelling has subsided. The current study evaluated the use of 
photocrosslinkable pentenoate-functionalized hyaluronic acid (PHA) and non-
crosslinking hyaluronic acid (HA) hydrogels encapsulating naturally derived 
tissue particles of demineralized bone matrix (DBM), devitalized cartilage (DVC), 
devitalized meniscus (DVM), or devitalized tendon (DVT) for bone regeneration 
in critical-size rat calvarial defects. The commercial product DBX® was used as 
   
4Submitted as: Townsend JM, Andrews BT, Feng Y, Wang J, Nudo RJ, Van Kampen E, 
Gehrke SH, Berkland CJ, Detamore MS. Superior Calvarial Bone Regeneration using 
Pentenoate-Functionalized Hyaluronic Acid Hydrogels with Devitalized Tendon Particles. Acta 
Biomaterialia, 2017. 
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the positive control for the study. The HA-DBM (4-30%), PHA (4%), and PHA-
DVT (4-30%) groups had 5 (p < 0.0001), 3.1, and 3.2 (p < 0.05) times greater 
regenerated bone volume compared to the sham (untreated defect) group, 
respectively. In vitro cell studies suggested that the PHA-DVT (4-10%) group 
would have the most desirable performance. Overall, hydrogels containing DVT 
particles outperformed other materials in terms of bone regeneration in vivo and 
calcium deposition in vitro. Hydrogels containing DVT will be further evaluated in 
future rat TBI studies.  
Introduction 
 Traumatic brain injury (TBI) is a life-threatening condition characterized by 
internal brain swelling, the degree of which can vary greatly. TBI inflicted by a 
closed head injury or stroke can result in severe brain swelling requiring surgical 
intervention.(109) The current surgical procedure to treat severe TBI involves a 
two-stage surgery. In the first surgery, decompressive craniectomy (DC) is 
performed to remove a large portion of the calvarial bone and allow un-impeded 
brain swelling.(146) The size of calvarial bone removed during DC is considered 
a critical size defect as the bone will not naturally heal by itself. After brain 
swelling has subsided, a second surgery—termed cranioplasty—is performed to 
close the cranial vault.(131) The average time between DC and cranioplasty has 
been reported up to 80 days; during this time the brain is left unprotected. 
Syndrome of the trephined (SoT), also known as sinking skin flap syndrome, is a 
severe neurological condition associated with mood changes, fatigue, dizziness, 
motor skill problems, and concentration issues.(116) The occurrence of SoT has 
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been connected to patients following DC for the treatment of TBI.(114) The cause 
of SoT has been attributed to various factors such as changing intracranial 
pressure,(147) and physical distortion of the brain from the weight of the 
scalp.(148) Immediate relief from SoT has been observed directly after 
cranioplasty,(114) and it is recommended that cranioplasty be performed as soon 
as clinically possible to mitigate the occurrence of SoT.(148) The current two-
stage surgical treatment is non-advantageous as it prolongs patient recovery by 
requiring two separate surgeries and potentially results in the neurological 
condition SoT.  
 Various research groups have reported new approaches to treat TBI. 
Martin et al.(123) previously studied the effect of a single-surgical approach 
combining DC and autologous bone flap cranioplasty in a pediatric patient 
population and found high complication rates. A potential issue with combining 
DC and cranioplasty in a single surgical intervention is that current methods, such 
as autologous bone flap cranioplasty, do not allow the brain to swell as the 
constructs are rigid bodies. Currently there is an unmet need for a material that 
can be implemented in a single-stage surgery to treat TBI, capable of remaining 
flexible during brain swelling, then transitioning to bone after brain swelling has 
ceased. Most research into TBI treatment has focused on methods to improve 
brain tissue healing(119, 135-138) or blocking tissue growth to ease the transition 
between DC and cranioplasty.(111) Currently available commercial bone void 
fillers cannot be used for cranioplasty following DC as the treatments are unable 
to regenerate sufficient bone across the critical size defect and do not remain 
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pliable after implantation. The first step in designing a material for TBI treatment 
after DC is to identify a pliable material capable of regenerating bone across a 
critical size defect. Once a pliable material that can sufficiently regenerate bone 
has been identified, the next logical step would be testing in a TBI animal model.  
 The objective of the current study was to evaluate the use of a 
photocrosslinking hyaluronic acid (HA) hydrogel encapsulating devitalized tissue 
particles for calvarial bone regeneration in a critical size calvarial defect. The use 
of a photocrosslinking hydrogel for calvarial bone regeneration represents a next-
generation biomaterial following our previous work.(36, 103) In the current study, 
hydrogels encapsulating tissue particles were created by combining pentenoate 
functionalized hyaluronic acid (PHA) or non-crosslinking hyaluronic acid (HA) 
with demineralized bone matrix (DBM), devitalized cartilage (DVC), devitalized 
meniscus (DVM), or devitalized tendon (DVT) particles. PHA hydrogels are an 
attractive material choice as the crosslinking time is on the range of 1-2 minutes. 
Compared to other options like methacrylated HA, which has a crosslinking time 
on the range of 5-10 minutes, a faster crosslinking time is desirable for the 
addition of cells or for surgical use.(149-153) The use of hydrogels by surgeons 
is often overlooked during the hydrogel design process. Hydrogel precursor 
handling properties can be tuned specifically with the surgeon in mind, 
developing paste-like precursor solutions to aid in material placement to ease 
clinical translation.(35) 
 The use of different extracellular matrix (ECM) materials for calvarial bone 
regeneration attempts to apply and recapitulate part of the endochondral 
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ossification process by delivering an intermediate material to accelerate 
healing.(108) Cartilage, meniscus, and tendon tissues were selected as they are 
comprised of varying amounts of collagen I or collagen II and may provide 
additional bioactive signals to promote healing. Crosslinking (i.e., PHA) and non-
crosslinking (i.e., HA) tissue hydrogels with a single colloidal loading of 30% were 
evaluated in a critical size rat calvarial defect model and groups with significant 
bone regeneration were refined explored in vitro. We hypothesized that ECM 
from sources other than bone would promote comparable or superior bone 
regeneration in a critical-size calvarial defect.  
 
Materials and Methods 
Preparation of Devitalized Tissue 
 Cartilage, meniscus, and tendon tissues were harvested from the knees 
of 10 castrated male Berkshire hogs (7-8 months of age, 120 kg) purchased from 
the local abattoir (Bichelmeyer Meats, Kansas City, KS). Tissue devitalization 
was described in our previous publication.(48) Briefly, harvested tissues were 
rinsed, strained, and chopped into small pieces. Tissues were coarse ground 
using a cryogenic tissue grinder (BioSpec Products, Bartlesville, OK) then frozen 
and lyophilized. Tissues were then cryoground using a freezer-mill (SPEX 6775, 
SamplePrep, Metuchen, NJ). Devitalized cartilage (DVC), devitalized meniscus 
(DVM), and devitalized tendon (DVT) particles were stored at -20°C for later use.  
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Synthesis of Pentenoate Functionalized Hyaluronic Acid (PHA) 
 Pentenoate functionalized hyaluronic acid (PHA) was synthesized as 
previously described.(154, 155) hyaluronic acid (HA, Mw = 1.01-1.8 MDa, 
Lifecore Biomedical, Chaska, MN) was dissolved in DI water at a concentration 
of 0.5% (w/v). Once fully dissolved, DMF was slowly added to the solution to 
achieve a final ratio of 3:2 (water:DMF). The pH of the solution was then adjusted 
to 9.5 using 1M NaOH. Pentenoic anhydride (Cat# 471801, Sigma-Aldrich, St. 
Louis, MO) was added in 5 M excess relative to HA and the pH was maintained 
between 8-9 for approximately 2 hours. Afterwards, NaCl was added to the 
solution to achieve a final concentration of 0.5 M. The PHA was then precipitated 
in four volumes of acetone and centrifuged at 7,000 x g to separate the PHA from 
solution. PHA pellets were then dissolved in DI water and transferred to dialysis 
packets (MWCO: 6-8 kDa). PHA was dialyzed against DI water for 48 hours, 
performing DI water exchanges every 12 hours. After dialysis, the PHA solution 
was frozen and lyophilized. Dry PHA was stored at -20°C for later use.  
 
Hydrogel Preparation 
 Hydrogels were prepared as previously described.(36) Briefly, HA or PHA 
and tissue particles were weighed dry and combined. HA groups were 
resuspended in phosphate buffered saline (PBS, Cat# P3813, Sigma-Aldrich) 
solution, and PHA groups were resuspended in PBS solution containing 2.3 mM 
of 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure 2959, Cat# 
410896, Sigma-Aldrich) and 1% dithiothreitol (DTT, Cat# D0632, Sigma-Aldrich). 
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Dry material combinations were sterilized using ethylene oxide gas (AN74i, 
Anderson Anprolene, Haw River, NC) and the PBS-I2959-DTT solution was 
sterile-filtered prior to resuspending PHA groups for use in vivo or in vitro. 
Hydrogel precursor solutions were allowed to reach ambient conditions for 2 h 
before implanting. Groups are presented as the material contents followed by 
weight per volume (in PBS) percentages of each in parentheses (i.e. PHA-DVC 
(4-30%) = 4% PHA + 30% DVC in PBS).  
 
Rheological Testing of Hydrogel Precursor  
 Hydrogel precursor yield stress (n = 3) was determined using a DHR-2 
controlled stress rheometer (TA Instruments, New Castle, DE). Measurements 
were performed using a 20-mm diameter crosshatched stainless steel plate 
geometry and a crosshatched Peltier plate cover at 37°C and a gap distance of 
500 µm. The Peltier solvent trap was used to ensure the material did not 
dehydrate during testing.  An oscillatory shear stress sweep from 10-5000 Pa 
was used to measure hydrogel precursor yield stress. Material yield stress was 
defined as the cross-over point of the storage (G’) and loss modulus (G”).(2)  
 
Mechanical Testing of Crosslinked Hydrogel 
 Crosslinked hydrogel compressive moduli (n = 5) were determined using 
an RSA III dynamic mechanical analyzer (TA Instruments). Crosslinked 
hydrogels were prepared using a previously published protocol.(35) Briefly, 
hydrogel precursor solutions were loaded into 2-mm thick Teflon molds 
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sandwiched between glass microscope slides and secured using clamps. 
Hydrogels were then crosslinked using a 312 nm UV-light at 9 mW/cm2 for 2 
minutes (EB-160C, Spectroline, Westbury, NY). Post-crosslinking, circular 
hydrogels cylinders were cut using a sterile 3 mm punch and swelled in PBS for 
24 hours before proceeding with mechanical testing. Swollen hydrogels were 
measured using a stereomicroscope and micrometer to determine the diameter 
(3.75 ± 0.1 mm), and hydrogel height (2.75 ± 0.1 mm) was measured using the 
RSA III. Hydrogels were compressed at a constant rate of 0.005 mm/s until 30% 
strain. The compressive modulus was calculated from the linear portion slope of 
the stress-strain curve between 5-15% strain.  
 
Animal Model and Surgical Method 
 Animal experiments were approved by the Institutional Animal Care and 
Use Committee of the University of Kansas Medical Center (protocol #2015-
2303). Male Sprague-Dawley rats were purchased from Charles River 
Laboratories (Wilmington, MA) at an age of 7-8 weeks; surgeries were conducted 
between 8-9 weeks of age. The calvarial bone was exposed by creating an 
incision on the posterior periphery of the skull to pull back the skin and 
periosteum. Using a dental trephine, a critical-size 7.5 mm diameter defect was 
created on the center of the calvarial bone. The circular piece of calvarial bone 
was carefully removed, leaving the dura mater intact. Approximately 50 µL of 
hydrogel paste was then syringed into the space and smoothed/shaped to the 
defect using a sterile spatula. Groups containing PHA hydrogel were then 
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crosslinked using a handheld 312 nm UV-light using a 312 nm UV-light at 9 
mW/cm2 for 2 minutes (EB-160C, Spectroline). The skin and periosteum were 
carefully draped over the defect site and sutured in place. The sham (untreated 
defect) group received the same surgical procedure without the addition of 
material, the DBX® group received approximately 50 µL of DBX® Putty, and the 
uninjured group received no surgical intervention. Calvarial bone was harvested 
after 8 weeks post-implantation (n = 5).  
 
Micro-Computed Tomography (µCT) 
 Micro-computed Tomography was performed using a Quantum FX 
imaging system (PerkinElmer, Waltham, MA) with a 50-kV X-ray source at 160 
µA. µCT imaging was conducted on harvested rat calvarial bone after 8 weeks 
post-implantation (n = 5). Scans were analyzed using Avizo computational 
software (FEI Company, Hillsboro, OR) to quantify regenerated bone volume. 
Regenerated bone was confirmed using pre-existing peripheral bone as the 
threshold. Total bone was determined using uninjured rat calvarial bone for 
determination of total bone regeneration percentage.  
 
Histology and Immunohistochemistry (IHC) 
 After fixing in 10% phosphate-buffered formalin for 48 hours and µCT 
imaging, explanted cranial bone samples were submerged in 70% ethanol for 
long-term storage. Embedding, sectioning, and staining of tissue was performed 
by the Stephenson Cancer Tissue Pathology Core at the University of Oklahoma 
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Health Sciences Center. Briefly, cranial implants with surrounding host bone were 
embedded in paraffin and sectioned in the sagittal plane following a standard 
protocol. Paraffin blocks were cut to a thickness of 4 µm and affixed to glass 
microscope slides. The SelecTech hematoxylin and eosin (H&E) staining system 
(Leica Biosystems, Wetzlar, Germany) was performed using a Leica ST5020 
multistainer (Leica Biosystems) following the manufacturer’s protocol (n = 5). 
 
In Vitro Cell Culture and Experimental Design 
 Pre-osteoblast mouse calvarial cells (MC3T3-E1, ATCC, Manassas, VA) 
were cultured in minimum essential medium- (Cat# 12561072, Thermo Fisher 
Scientific, Waltham, MA) supplemented with 10% fetal bovine serum (FBS, Cat# 
16000044, Thermo Fisher Scientific) and 1% penicillin/streptomycin (Cat# 
15140-122, Thermo Fisher Scientific). Medium was exchanged every other day 
and cells were cultured to a passage number of 2 before being used in the study. 
Experimental groups from the 8-week in vivo study that significantly outperformed 
the negative control (p < 0.05) were chosen to be refined in vitro to determine the 
minimum tissue particle concentration to achieve a desirable cellular response. 
Following the results of the in vivo study; PHA, PHA-DBM, and PHA-DVT groups 
were selected to evaluate the tissue particle concentration from 10 to 30%. 
Approximately 50 L of material was injected by syringe into each well of a 96-
well plate, centrifuged at 1000 x g for 5 minutes to evenly coat the bottom of the 
well, then crosslinked using the handheld UV light for 2 minutes. MC3T3-E1 cells 
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were seeded at a concentration of 104 cells per well (150 L volume) directly on 
top of the crosslinked material in each well of the 96-well plate (n = 5). 
 
Biochemical Assays 
 After 2 and 10 days of cell culture, seeded cells were lysed with 200 L of 
lysis buffer (Cat# R1060-1-50, Zymo Research, Irvine, CA) and DNA content was 
determined using the Quant-iTTM PicoGreenTM assay (Cat# P7589, Thermo 
Fisher Scientific) according to the manufacturer’s protocol (n = 5). Hydrogels 
without seeded MC3T3 cells served as controls for the study, designated as the 
tissue culture plastic (TCP) group. Hydrogel constructs were then dissolved in 
100 L of 1M hydrochloric acid to determine the amount of deposited calcium. 
Calcium was assayed using the QuantiChromTM calcium assay kit (BioAssay 
Systems, Hayward, CA) according to the manufacturer’s protocol (n = 5).  
 
Statistical Methods 
 GraphPad Prism (GraphPad Software Inc, La Jolla, CA) software was 
used to conduct all statistical analyses. A one-way analysis of variance with 
groups of factors was used for analyzing mechanical testing and CT results, and 
a two-way analysis of variance with groups of factors was used to analyze 
biochemical assays. Tukey’s post-hoc analysis was used to compare between 
groups. Yield stress testing had n = 3 samples per group. Compressive modulus, 
µCT, DNA, and calcium testing had n = 5 samples per group; all data are reported 
as the mean ± the standard deviation. 
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Results 
Rheological Analysis of Hydrogel Precursor 
 All material formulations tested exhibited a yield stress (𝜏𝑦 > 200 Pa, Fig. 
1A). The addition of ECM particles to PHA significantly increased the material 
yield stress in all groups except for the PHA-DVT (4-10%) group. PHA-DVC (4-
30%), PHA-DVM (4-30%), PHA-DBM (4-30%), PHA-DVT (4-20%), and PHA-
DVT (4-30%) had 23.1, 12.8, 14.8, 8.4, and 10.4 times greater yield stresses 
compared to the control PHA (4%) group (206 Pa) (p < 0.0001). PHA-DBM (4-
10%) and PHA-DBM (4-20%) had 6.3 and 5.8 times greater yield stresses 
compared to the PHA (4%) group (p < 0.05). The PHA-DVC (4-30%) group (4760 
Pa) had the highest yield stress, which was 1.8, 3.7, 4.0, 1.6, 5.3, 2.8, and 2.2 
times greater than those of the PHA-DVM (4-30%), PHA-DBM (4-10%), PHA-
DBM (4-20%), PHA-DBM (4-30%), PHA-DVT (4-10%), PHA-DVT (4-20%), and 
PHA-DVT (4-30%) groups, respectively (p < 0.0001). The PHA-DVM (4-30%) 
group (2644 Pa) had a yield stress that was 2.0, 2.2, and 2.9 times greater than 
those of the PHA-DBM (4-10%), PHA-DBM (4-20%), and PHA-DVT (4-10%) 
groups, respectively (p < 0.0001), and 1.5 times greater than that of the PHA-
DVT (4-20%) group (p < 0.05). The PHA-DBM (4-30%) group (3060 Pa) had a 
yield stress that was 2.4, 2.6, and 3.4, times greater than those of the PHA-DBM 
(4-10%), PHA-DBM (4-20%), and PHA-DVT (4-30%) groups, respectively (p < 
0.0001), and 1.8 times greater than that of the PHA-DVM (4-20%) group (p < 
0.001), and 1.4 times greater than that of the PHA-DVT (4-30%) group (p < 0.05). 
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The PHA-DVT (4-30%) group (2154 Pa) had a yield stress 1.7, 1.8, and 2.4 times 
greater than that of the PHA-DBM (4-10%), PHA-DBM (4-20%), and PHA-DVT 
(4-10%) groups, respectively (p < 0.05).    
 
Mechanical Analysis of Crosslinked Hydrogel 
 The addition of ECM particles increased the average compressive 
modulus of all hydrogels tested (Fig. 1B). The PHA-DVC (4-30%), PHA-DVT (4-
20%), and PHA-DVT (4-30%) groups respectively had 7.6, 3.2, and 2.5 times 
greater compressive moduli compared to the PHA (4%) group (7.4 kPa) without 
ECM particle (p < 0.01). PHA-DVC (4-30%) had a compressive modulus that was 
2.5 times greater than that of the PHA-DVM (4-30%) group (p < 0.05), and 4, 2.7, 
and 3 times greater than those of the PHA-DVT (4-10%), PHA-DBM (4-10%), and 
PHA-DBM (4-30%) groups, respectively (p < 0.001), and 2.4 times greater than 
that of the PHA-DBM (4-20%) group(p<0.01). The PHA-DVT (4-20%) group had 
a compressive modulus that was 3.2 times greater than that of the PHA-DVT (4-
10%) group (p < 0.05). The addition of ECM particles in DBM groups did not 
significantly increase the compressive modulus; however, a statistically 
significant increase in compressive modulus was observed in PHA-DVT groups 
with increasing ECM particles.     
 
Micro-computed Tomography (µCT) Analysis 
 Significant bone regeneration was not observed in non-crosslinking HA-
ECM formulations, except for the HA-DBM (4-30%) group (Fig. 2). Large bone 
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island formation was observed in all PHA groups; however, minimal bone-
bridging was observed. The HA-DBM (4-30%) group (67.1%) had 5, 4.2, 6.4, 6.3, 
3.6, and 2.9 times greater percent bone volume regeneration compared to the 
sham, HA-DVC (4-30%), HA-DVM (4-30%), HA-DVT (4-30%), PHA-DVC (4-
30%), and PHA-DVM (4-30%) groups, respectively (p < 0.0001). HA-DBM (4-
30%) also had 2.4 times (p < 0.01) and 1.8 times (p < 0.05) times greater percent 
bone volume regeneration compared to the DBX® and PHA-DBM (4-30%) 
groups, respectively. The PHA (4%) group (41.9%) had 3.1, 4, and 3.9 times 
greater percent bone volume regeneration compared to the sham, HA-DVM (4-
30%), and HA-DVT (4-30%), respectively (p < 0.05). The PHA-DVT (4-30%) 
group (42.4%) had 3.2, 4.1, and 4 times greater percent bone volume 
regeneration compared to the sham, HA-DVM (4-30%), and HA-DVT (4-30%), 
respectively (p < 0.05).  
 
Histological Analysis 
 Bone growth at the defect periphery was observed in all samples and 
formed toward the dural side of the defect (Fig. 3). A noticeable soft tissue 
formation was observed in the defect space where bone formation was absent. 
Thicker bone formation was observed in hydrogel groups with PHA compared to 
HA groups. Peripheral bone growth spanning into the defect site was observed 
at a higher rate in PHA hydrogel groups. Disjoined DBM particles were observed 
in the defect space for both the HA and PHA hydrogels and did not appear to 
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integrate with the regenerated bone. DVC, DVM, and DVT tissue particles were 
not observed in any group after the 8 week recovery time.  
 
Biochemical Analysis from In Vitro Study 
 After 2 days of cell growth, DNA content was by far the highest for the 
PHA-DVT (4-30%) group (14.2 µg/mL), significantly outperforming all other 
groups (Fig. 4A). Specifically, this PHA-DVT (4-30%) group at day 2 had 6.9, 
18.1, 19, 15.6, 13, 6.4, and 3.5 times greater DNA content compared to the TCP, 
PHA (4%), PHA-DBM (4-10%), PHA-DBM (4-20%), PHA-DBM (4-30%), PHA-
DVT (4-10%), and PHA-DVT (4-20%) groups at day 2, respectively (p < 0.0001). 
After 10 days of cell culture on hydrogel groups, the only group with a significant 
increase in DNA content was the TCP group. The TCP group (12.7 µg/mL) at day 
10 had had 6.1 times greater DNA content compared to TCP at day 2 (p < 
0.0001). The TCP group at day 10 had 21.5, 19.3, 11.7, 10.6, 17.5, and 3.9 times 
greater DNA content compared to the PHA (4%), PHA-DBM (4-10%), PHA-DBM 
(4-20%), PHA-DBM (4-30%), PHA-DVT (4-10%), and PHA-DVT (4-20%) groups, 
respectively (p < 0.001). The PHA-DVT (4-30%) group (18.4 µg/mL) at day 10 
had 31.2, 28, 16.9, 15.4, 25.4, and 5.6 times greater DNA content compared to 
the PHA (4%), PHA-DBM (4-10%), PHA-DBM (4-20%), PHA-DBM (4-30%), 
PHA-DVT (4-10%), and PHA-DVT (4-20%) groups, respectively (p < 0.0001). 
 Calcium assayed at days 2 and 10 showed a significant increase of 
calcium content in hydrogels containing devitalized tendon. The TCP group had 
a near zero result (Fig. 4B). PHA-DVT (4-10%) (8.44 mg/dL), PHA-DVT (4-20%) 
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(8.78 mg/dL), and PHA-DVT (4-30%) (6.82 mg/dL) at day 10 had increases of 
2.8, 2.7, and 3.3 times compared to day 2, respectively (p < 0.0001). At day 10, 
The PHA-DVT (4-10%) group had 2.2, 1.6, 3.1, and 6.3 times greater calcium 
content compared to the PHA (4%), PHA-DBM (4-10%), PHA-DBM (4-20%), and 
PHA-DBM (4-30%), respectively (p<0.0001). The PHA-DVT (4-20%) group at 
day 10 had 2.3, 1.7, 3.2, and 6.6 times greater calcium content compared to PHA 
(4%), PHA-DBM (4-10%), PHA-DBM (4-20%), and PHA-DBM (4-30%), 
respectively (p < 0.0001). The PHA-DVT (4-30%) group at day 10 had 1.8, 2.5, 
and 5.1 times greater calcium content compared to the PHA (4%), PHA-DBM (4-
20%), and PHA-DBM (4-30%) groups, respectively (p < 0.05). The PHA-DBM (4-
10%) group (5.17 mg/dL) at day 10 had 3.9 times greater calcium content 
compared to the PHA-DBM (4-30%) group (p < 0.001). No significant differences 
were observed among day 2 groups.  
 
Discussion 
 The current study was the first to evaluate multiple sources of extracellular 
matrix materials for bone regeneration in a critical size calvarial defect. Hydrogels 
presented in the current study demonstrated desirable paste-like handling 
properties for surgical placement and fast crosslinking times. The current study 
represents the next generation of materials following our previous work using 
micron-sized decellularized cartilage and hydroxyapatite for calvarial bone 
regeneration in vivo.(36, 37) In designing hydrogels for the current study, aspects 
such as mechanical performance, both solid (post-crosslinking) and fluid (pre-
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crosslinking), were determined to be of great importance for clinical translation 
and future application to TBI treatment.(20) Mechanical performance of the 
hydrogel precursor solution and the crosslinked hydrogel, specifically the 
precursor solution yield stress and the crosslinked hydrogel compressive 
modulus, respectively, were determined to be vital parameters to demonstrate 
feasibility for material placement and retention. All hydrogel precursors (prior to 
crosslinking) exhibited adequate yield stress (𝜏𝑦 > 200 Pa) for material 
placement, and the addition of tissue particles increased the average yield stress 
of all groups. For context, the yield stress of common household items such as 
mayonnaise and Play-Doh are 200 and 3000 Pa, respectively.(67) The addition 
of 30% cartilage particles had the greatest effect on material yield stress, 
potentially due to the presence of the charged proteoglycan,  aggrecan.(156) 
Only PHA-containing groups were evaluated for yield stress as the rheological 
differences between HA and PHA were assumed to be negligible. After material 
crosslinking to form hydrogels, the average compressive modulus increased for 
the groups containing particles; however, the result was only significant in the 
DCC and some DVT-containing groups. The significant increase in compressive 
modulus for the DVC and DVT groups was speculated to be attributed to material 
interaction between the PHA hydrogel and the tissue particle. Although the 
compressive moduli of the hydrogels tested in the current study were relatively 
low, the stiffness does not necessarily need to meet that of native bone (i.e., GPa) 
due to the TBI application requiring flexibility of the biomaterial.(141)  
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 One of the more striking results of the current study was that in vivo bone 
formation differed greatly between the HA- and PHA-containing groups. Both HA 
and PHA were evaluated due to the speculation that hydrogel crosslinking may 
influence cellular infiltration. For every group besides the DBM containing group, 
average bone formation was greater when the tissue was combined with PHA 
rather than non-crosslinking HA. Due to the aforementioned observation, 
hydrogel formation may potentially aid in regeneration by providing a three-
dimensional framework; however, the hydrogel may also impede access to the 
colloidal material as demonstrated by the CT results. The speculation that the 
PHA hydrogel crosslinking may potentially impede cellular infiltration was 
debunked for the PHA hydrogels in the current study as demonstrated by H&E 
staining. Interestingly, the positive control of DBX® had less bone regeneration 
compared to both HA-DBM and PHA-DBM. DBX® contains approximately 31% 
cortical bone and 4% hyaluronic acid (Mw = 1 MDa) by weight and would be 
expected to have similar bone regeneration compared to the non-crosslinking 
HA-DBM (4-30%) group that had approximately 22% cortical bone by 
weight.(157) The major difference of DBX® comparatively to HA-DBM (4-30%) 
and PHA-DBM (4-30%) being the hyaluronic acid molecular weight and bone 
concentration. The PHA (4%) control group similarly demonstrated greater 
average bone regeneration compared to DBX®; however, the finding was not 
significant. Another study used an 80 kDa, 30 wt% maleimide-modified HA 
(MaHA) hydrogel tested in a critical size rat calvarial defect and reported less 
bone regeneration on average compared to the current study.(87) Noting 
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differences of the MaHA hydrogel compared to the current study of HA molecular 
weight, concentration, and crosslinking mechanism, histological analysis 
demonstrated that the MaHA gel remained after 8 weeks of recovery. No 
hydrogel persisted after 8 weeks of recovery in the current study as demonstrated 
by H&E staining. Further investigation into the relationship between hyaluronic 
acid molecular weight and bone regeneration is recommended to fully understand 
the use of the polymer in bone regeneration. 
 Other groups have evaluated the use of different extracellular matrices for 
bone regeneration. One such group demonstrated desirable bone regeneration 
in a mouse calvarial defect model using scaffolds derived from decellularized 
bovine Achilles tendon seeded with human adipose-derived stem cells.(158) 
Another group proposed the use of different ECM materials for general hydrogel 
applications, in which photocrosslinking hydrogels composed of methacrylated 
gelatin and solubilized-methacrylated-ECM (i.e., cartilage, meniscus, and 
tendon) were created and tested for in vitro gene expression.(145) Perhaps the 
majority of focus into new ECM materials for bone regeneration has been 
targeted at using cartilage as a material for bone regeneration.(36, 128, 143, 144) 
Although other groups have demonstrated promise for cartilage as a material to 
facilitate bone regeneration, including our own group, the current study 
demonstrated minimal regeneration compared to previous studies as indicated 
by µCT and H&E staining.   
 Groups with significantly greater bone regeneration compared to the sham 
were selected for further refinement in vitro to determine the most attractive tissue 
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particle concentration for future application to TBI treatment. PHA (4%), PHA-
DBM (4-30%), and PHA-DVT (4-30%) were selected for further refinement. 
Although the HA-DBM (4-30%) group had the largest bone regeneration in the 
current study, a crosslinking hydrogel is necessary for application to TB 
treatment, thus the PHA-DBM (4-30%) group was included due to the large bone 
regeneration observed in the HA-DBM (4-30%) group. Material crosslinking is 
necessary for potential application to a single surgical intervention to treat TBI, 
thus refining the material to determine the minimum particle concentration to 
achieve maximum crosslinking was explored. In vitro studies demonstrated 
significantly greater proliferation on the PHA-DVT (4-30%) group, potentially 
attributed to greater initial cellular adhesion during seeding. Interestingly, cellular 
number did not significantly change over 10 days on the hydrogel groups. Initial 
calcium deposition was relatively the same for hydrogel groups after 2 days of 
culture, but significantly increased on hydrogels containing DVT by 10 days. 
Overall, DVT hydrogels outperformed other crosslinked hydrogels and calcium 
deposition suggested that the most desirable particle concentration would be 
10%. Future studies will focus on using the refined particle concentration in a rat 
TBI model.   
 
Conclusion 
 The current study demonstrated the feasibility of PHA hydrogels 
encapsulating ECM tissue particles for use in calvarial bone regeneration. 
Desirable paste-like handling properties of the pre-crosslinked hydrogels, and 
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mechanical performance after crosslinking was demonstrated in the current study 
for relevance to TBI. The addition of tissue particles increased both the yield 
stress and compressive modulus of the material on average, with the cartilage 
particles leading to the greatest yield stress. The PHA (4%) and PHA-DVT (4-
30%) groups led to the greatest bone regeneration, and the tendon particles 
likewise demonstrated superior calcium deposition by MC3T3 cells in vitro, with 
10% DVT appearing to be the most desirable concentration. Future studies will 
attempt to evaluate leading materials in an in vivo rat TBI model.  
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Chapter 6: Conclusion 
 The current dissertation has successfully identified a pliable hydrogel 
material capable of regenerating bone in a critical size calvarial defect with 
potential application to the treatment of traumatic brain injury (TBI). Hydrogels 
are an attractive choice for regenerative medicine approaches, highlighting their 
capability for in situ placement to fill any size or shape of tissue defect, a 
secondary crosslinking mechanism to ensure retention at the site of application, 
pliability after crosslinking for tailored application such as TBI, and the inherent 
ability to encapsulate other materials or biosignals for specific tissue 
regeneration. The hydrogel precursor performance can be further tailored with 
clinical translation in mind, creating precursor solutions that exhibit paste-like or 
putty-like handling properties for ease of placement. For the aforementioned 
reasons, hydrogels were selected for application in calvarial bone regeneration 
and treatment of TBI.  
 To successfully create a hydrogel material for application to a single-stage 
TBI treatment the material must remain pliable after initial implantation to allow 
un-impeded brain swelling, prevent the manifestation of neurological conditions, 
and regenerate bone spanning a critical size defect. Hydrogels are inherently 
pliable after crosslinking, thus the first step in designing hydrogels for TBI 
application is to create a hydrogel that can adequately regenerate bone in a 
critical size defect. Predecessors of the current dissertation have evaluated the 
use of physical “colloidal gels” comprised of synthetic particles capable of tailored 
biosignal release to promote calvarial bone regeneration.(31, 32, 34, 37, 103, 
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108) The colloidal gels were capable of exhibiting desirable paste-like handling 
properties for placement and demonstrated promising in vitro cell response. The 
encouraging results from predecessors using colloidal gels prompted their use in 
the current dissertation, marking the beginning of the research presented. 
 Colloidal hydrogels comprised of hyaluronic acid (HA), hydroxyapatite 
nanoparticles (HAp), and extracellular matrix (ECM) materials of demineralized 
bone matrix (DBM) or decellularized cartilage (DCC) exhibited ideal handling 
performance for implantation. Comparing the use of ECM materials to growth 
factors such as bone morphogenetic protein-2 (BMP-2) or vascular endothelial 
growth factor (VEGF), similar bone regeneration was observed between the HA-
HAp (BMP-2) group and the HA-HAp-DCC group. DBM containing groups on 
average had lower bone regeneration compared to the HA-HAp-DCC group, 
suggesting that materials other than the traditional DBM could be used for bone 
regeneration. The aforementioned findings suggested that ECM materials could 
be used in place of costly growth factors to create clinically translatable products 
and prompted additional research using DCC in bone regeneration. One major 
down-fall of the colloidal gels used in Aim 1 was the lack of a crosslinking 
mechanism, which resulted in material retention issues, which I believe may have 
led to diminished regenerative potential. To circumvent the material retention 
issue observed and further evaluate the use of cartilage ECM as a material for 
bone regeneration, a crosslinking hydrogel material was selected for subsequent 
studies. 
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 Predecessors of this work had previously developed a crosslinking 
hydrogel matrix comprised of naturally derived decellularized cartilage matrix for 
use in cartilage regenerative medicine.(48, 89) The methacrylated solubilized 
decellularized cartilage (MeSDCC) hydrogel exhibited desirable handling 
performance prior to crosslinking, high mechanical stiffness after crosslinking, 
and the ability to encapsulate nano- and micron-size particles. The MeSDCC 
hydrogels were an attractive material choice to address material retention issues 
while expanding upon the use of cartilage ECM for bone regeneration in aim 2 
studies. 
 MeSDCC could be further refined for bone regeneration by the addition of 
rat mesenchymal stem cells, or synthetic osteoconductive particles of bioglass 
microparticles or hydroxyapatite nanofibers. MeSDCC results following the 8 
week in vivo study were lackluster in terms of bone regeneration. Clear 
differences in average bone regeneration were observed between the use of 
DCC and MeSDCC, prompting speculation into why these potential differences 
may exist. Tissue processing was speculated to be the major contributing factor, 
as tissue solubilization using protein digestion most likely diminished ECM 
bioactivity by degrading the ECM into unrecognizable components. For future 
studies, utilizing cartilage it is highly recommended to minimize tissue processing 
to retain material bioactivity, thus cartilage devitalization is an attractive 
approach. Devitalization, which is similar to decellularization, only incorporates 
physical processing (i.e., granulating) methods without the additional step of 
chemical decellularization. To retain material bioactivity, both tissue 
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decellularization and solubilization were excluded from future studies to retain 
material bioactivity. One major drawback associated with the exclusion of tissue 
decellularization was that there could now be potential for an immune response 
due to foreign tissue. Although this concern was noted at the time, ECM sources 
selected were generally acellular and did not require decellularization during 
allogenic tissue implantation.  
 In moving forward, the objective was to combine the bone regeneration 
observed in aim 1 with the crosslinking of aim 2. Additionally, ECM sources such 
as demineralized bone matrix (DBM), devitalized cartilage (DVC), devitalized 
meniscus (DVM), and devitalized tendon (DVT) were included to expand the 
evaluation of different ECM materials for bone regeneration. Both non-
crosslinking HA and crosslinking HA hydrogels were evaluated for In vivo bone 
regeneration after 8 weeks. Significant bone regeneration was observed for the 
HA-DBM (4-30%), PHA (4%), and PHA-DVT (4-30%) groups compared to the 
sham. I then sought to refine the colloidal particle concentration to determine the 
minimum concentration required to achieve the highest crosslinking density for 
application to TBI and the most economically feasible formulation for clinical 
translation and affordability. Due to the HA-DBM (4-30%) group not being able to 
crosslink, the PHA-DBM (4-30%) group was included in the in vitro colloidal 
refinement study. Calcium deposition suggested superior bone regeneration from 
the PHA-DVT (4-10%) group, and overall the most attractive material for 
application to a single-stage surgical intervention to treat TBI. In hindsight, further 
in vitro analysis and refinement of groups following the in vivo study would have 
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increased confidence in the colloidal refinement. Multiple time points, and a 
longer overall study time may have helped reassure and better pinpoint the most 
attractive colloidal concentration. Before additional in vivo work is conducted, it is 
strongly recommended that the in vitro study is repeated with time points of 14 
and 21 days to better observe deposited calcium and include ELISA testing for 
osteogenic markers such as osteocalcin release.  
 In vivo testing prior to in vitro refinement was beneficial to the study as the 
in vivo animal model served as a reliable method to evaluate various osteogenic 
materials. The in vitro model, which provides less confidence compared to an in 
vivo animal model, acted to refine the superior groups rather than exclude 
groups. The route of performing in vivo before in vitro is uncommon within the 
field, potentially due to the associated monetary cost for animal studies. Although 
in vitro studies can be a cost-effective method for eliminating a large number of 
potential options, the reality persists that the in vitro model may not accurately 
depict the in vivo environment. For the aforementioned reasons, an iterative 
design between in vitro and in vivo models is recommended for future 
experimental designs. 
 A limitation of the current dissertation was the lack of physical evaluation 
of regenerated calvarial bone following the in vivo rat study. Various methods 
exist to mechanically characterize the regenerated bone such as indentation 
testing, which is used to determine the stiffness, or push-out testing, which is 
used to evaluate the interfacial strength. Although the mechanical 
characterization would be of potential value for comparing different materials in a 
 
 
104 
 
research setting, a clinician may be more interested in the extent of regenerated 
bone across the entire defect to ensure patient safety. Indentation mapping of the 
entire defect space may be the most relevant test to satisfy both scientists and 
medical professionals. Although indentation mapping would not provide 
information on the defect interfacial strength, it would provide information on the 
degree of bone stiffness at various points of the defect. 
 Although the greatest crosslinking hydrogel bone regeneration was 
observed using DVT, impressive bone regeneration was also observed in the 
control PHA hydrogel without the addition of ECM particles. Comparing to 
another study using a similar HA based hydrogel, which utilized a lower molecular 
weight (80 kDa), the average bone regeneration was greater for the higher 
molecular weight HA based hydrogel used in the current dissertation.(87) The 
difference in observed bone regeneration suggests further research is needed in 
the evaluation of HA as a material for bone regeneration. Publications utilizing 
HA based hydrogels rarely provide background information into the selection 
process for hydrogel characteristics such as the choice of molecular weight, 
concentration, and compressive modulus. The current dissertation is in part at 
fault for the same aforementioned reasons, and further research is necessary to 
understand how molecular weight, concentration, and hydrogel stiffness effects 
cellular response. Although the physical material component may only be a piece 
of the larger puzzle, a better understanding of how HA properties effect cellular 
response can lead to enhanced regenerative potential.   
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 The current dissertation has successfully identified a hydrogel material 
capable of regenerating bone in a critical size calvarial defect, utilizing natural 
materials as an affordable alternative to growth factors such as BMP-2, and 
capable of remaining pliable after initial implantation. Future studies will be 
conducted to evaluate the use of the PHA hydrogels encapsulating tendon ECM 
in a rat TBI model. At the time of writing the current dissertation, the rat TBI model 
was still under development. After successful development of the model by Dr. 
Brian Andrew’s team at the University of Kansas Medical Center, the hydrogel 
will be evaluated for application of the material for the treatment of TBI following 
decompressive craniectomy.  
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Figure 1.1: Illustration of Dissertation Aims  
Graphical illustration of the three specific aims evaluated in chronological order.   
 
  
 
 
129 
 
 
Figure 1.2: Illustration of Implanted Hydrogel Pliability 
Graphical illustration of an implanted hydrogel for treatment of traumatic brain 
injury following decompressive craniectomy. Note the pliability of the hydrogel 
to allow brain herniation during initial implantation.  
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Figure 2.1: Liquid, paste, and Putty Precursor Solutions 
Illustration of increasing precursor yield stress to achieve different material 
consistencies. Precursor materials with no yield stress exhibit liquid properties, 
and materials with increasing yield stress exhibit paste and putty hydrogel 
precursor properties.  
  
 
 
131 
 
 
Figure 2.2: Illustration of Real and Induced Defects  
Illustration depicting the difference between defects observed in patient 
populations (top) compared to defects used for in vivo studies (bottom). Common 
differences between actual injuries and defects used for research include shape, 
size, and orientation, and emphasize the clinical requirement of a hydrogel 
precursor solution that can be carefully molded as a paste and contoured to fit 
the defect site prior to crosslinking.  
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Figure 2.3. Defect Retention of Liquid Compared to Paste or Putty  
Illustration of how achieving paste or putty rheological properties in hydrogel 
precursor solutions can aid in material placement. (Left) Lack of material retention 
using an in situ liquid hydrogel precursor solution compared to (Right) precursor 
materials exhibiting desirable paste and putty behavior. 
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Figure 2.4: Methods to Determine Yield Stress  
Graph illustrations of methods to determine the yield stress of a material, black 
dots correspond to the yield stress. A) Theoretical model fitting using the 
Herschel-Bulkley (HB) model as an example. B) Determining the shear stress at 
the crossover point of the storage and loss modulus (G’/G”). C) Determining the 
shear stress related to a pre-determined deviation of the storage modulus from 
linearity (i.e. 85% deviation). As a general rule, we recommend the HB model to 
calculate the yield stress (𝜏0). 
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Figure 3.1: Surgical Method and Material ESEM Images 
A) Surgical method illustration shown in two steps, in the first (left) step the scalp 
is opened and a 7.5 mm cylindrical bone section is removed. The following step 
(right) involves filling the defect gap using a syringe loaded with one of the 
material groups and smoothing into place, before suturing the scalp back in place. 
B) Extruded and shaped material groups of HA-HAp, HA-HAp-DBM, and HA-
HAp-DCC. Material yield stress allowed for retention after shaping using a 
surgical spatula. Environmental scanning electron microscope images provide 
insight into the gel microstructure. Scale bars = 200 μm.  
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Figure 3.2: Aim 1 Hydrogel Precursor Yield Stress  
A-C) Representative rheometer traces for HA-HAp, HA-HAp-DBM, and HA-HAp-
DCC, respectively. D) Colloidal gel yield stress corresponding to a 15% deviation 
of G’ from linearity. Addition of DBM significantly increased the yield stress of the 
material compared to HA-HAp as indicated by an asterisk (p<0.01).  
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Figure 3.3: Aim 1 Regenerated Bone Volume and CT Imaging  
A) In vivo regenerated bone volume. Bone regeneration was evaluated after 8 
weeks using micro-computed tomography (μCT) analysis. Asterisks (**) 
represent statistically significant results (P<0.01) compared to the sham. Error 
bars represent standard deviations. B) μCT analysis using Avizo Fire software. 
Orange coloring indicating the regenerated bone, and blue coloring defining 
original colloidal particles. Scale bar represents 5 mm in length.  
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Figure 3.4: Aim 1 H&E Staining  
Histological analysis of critical size (7.5 mm) rat calvarial defects after 8 weeks 
post-implantation. Sections were taken in the sagittal plane with the dural side of 
the calvaria as the bottom of the image. Groups were analyzed using hematoxylin 
and eosin (H&E) to highlight new bone formation versus original colloidal 
material. Zoomed images correspond to the boxed area on the total defect area. 
scale bars = 1 mm 
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Figure 3.5: Aim 1 Immunohistochemistry 
Immunohistochemistry (IHC) results for collagen 1 (COL1), collagen 2 (COL2), Osteocalcin (OCN), and alpha-smooth 
muscle actin (αSMA). Brown coloring represents positive presence for the selected antibody, where blue staining represents 
negative antibody presence. All images represent in vivo healing of material groups after 8 weeks post-implantation. (*) 
corresponds to defect bone edge, scale bar = 1 mm. 
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Figure 4.1: Aim 2 Hydrogel Precursor Yield Stress 
A) Representative rheometer traces for Fib-HAPnf, MeSDCC, MeSDCC-HAPnf, 
and MeSDCC-BG hydrogel precursor solutions. B) Hydrogel yield stress 
determined by the crossover point of the storage (G’) and loss (G”) moduli. α = 
significant increase compared to MeSDCC (p<0.0001) and β = significantly larger 
value compared to the Fib-HAPnf group (p<0.0001). Addition of colloidal particles 
to MeSDCC significantly increased the yield stress by a factor of ~3. n = 5, values 
represent the mean  standard deviation. Fib = Fibrin, MeSDCC = Methacrylated 
Solubilized Decellularized Cartilage, HAPnf = Hydroxyapatite Nanofibers, BG = 
Bioglass. 
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Figure 4.2: Aim 2 Hydrogel Compressive Modulus  
A-B) Representative stress-strain curves for crosslinked hydrogel groups. C) 
Compressive modulus determined by the slope of the stress-strain curve 
between 10 and 20% strain. α = significant increase compared to the MeSDCC 
group (p<0.01) and β = significantly larger than Fib, Fib-HAPnf, and Fib-BG 
(p<0.0001). Addition of colloidal particles to MeSDCC significantly increased the 
compressive modulus by a factor of 4 to 5.5. n = 5, values represent the mean  
standard deviation. Fib = Fibrin, MeSDCC = Methacrylated Solubilized 
Decellularized Cartilage, HAPnf = Hydroxyapatite Nanofibers, BG = Bioglass. 
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Figure 4.3: Aim 2 Regenerated Bone Volume and CT Imaging 
Microcomputed tomography (µCT) analysis using Avizo software 8 weeks after 
implantation. A) Reconstructed µCT scans of calvarial defects. Orange coloring 
indicates regenerated bone to distinguish from existing bone. B) Regenerated 
bone volume determined by µCT. α = significantly greater bone volume compared 
to all other groups (p<0.05). Note that only the DBX® treatment group had a 
significantly larger bone volume compared to the sham. Scale bar = 5 mm. 
Asterisks (*) represent our previously published data (i.e., sham group).(36) n = 
5, values represent the mean  standard deviation. Fib = Fibrin, MeSDCC = 
Methacrylated Solubilized Decellularized Cartilage, HAPnf = Hydroxyapatite 
Nanofibers, BG = Bioglass. 
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Figure 4.4: Aim 2 H&E Staining 
Hematoxylin and eosin (H&E) histological analysis of critical size (7.5 mm) rat calvarial defects 8 weeks after implantation. 
Sections were taken in the sagittal plane with the dural side of the calvarium as the bottom of each image. Note that 
regeneration was limited in all groups except the DBX® group. Scale bar = 5 mm. Fib = Fibrin, MeSDCC = Methacrylated 
Solubilized Decellularized Cartilage, HAPnf = Hydroxyapatite Nanofibers, BG = Bioglass.  
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Figure 4.5: Aim 2 Immunohistochemistry 
Immunohistochemical (IHC) staining for collagen I and collagen II. Brown coloring indicates positive presence for the 
selected antibody, and the blue staining represents the hematoxylin counterstain. Note the positive collagen II staining in 
the MeSDCC-BG group, indicating leftover hydrogel after the 8-week recovery period. Scale bar = 500 µm. Fib = Fibrin, 
MeSDCC = Methacrylated Solubilized Decellularized Cartilage, HAPnf = Hydroxyapatite Nanofibers, BG = Bioglass.  
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Figure 5.1: Aim 3 Mechanical Characterization 
A) Hydrogel precursor yield stress determined by the crossover point of the 
storage (G’) and loss (G”) modulus (n = 3). Note increasing yield stress with DVT 
concentration. The highest yield stress observed in the DVC group. α = 
significantly larger value compared to PHA (4%) (p < 0.0001). β = significantly 
larger value compared to PHA (4%) (p < 0.05). µ = significantly larger value 
compared to all other groups (p < 0.0001). D = significantly larger value compared 
to PHA-DBM (4-10%), PHA-DBM (4-20%), and PHA-DVT (4-10%) (p < 0.0001). 
θ = significantly larger value compared to PHA-DVT (4-20%) (p < 0.05). λ = 
significantly larger value compared to PHA-DVT (4-20%) (p < 0.001). γ = 
significantly larger value compared to PHA-DVT (4-30%) (p < 0.05). π = 
significantly larger value compared to PHA-DBM (4-10%), PHA-DBM (4-20%), 
and PHA-DVT (4-10%) (p < 0.05).   B) Crosslinked hydrogel compressive 
modulus determined by the slope of the stress-strain curve between 5-15% (n = 
5). Note higher compressive moduli for hydrogels containing DVT or DVC. α = 
significantly larger value compared to PHA (4%) (p < 0.01). β = significantly larger 
value compared to PHA-DVM (4-30%) (p < 0.05). γ = significant larger value 
compared to PHA-DVT (4-10%), PHA-DBM (4-10%), and PHA-DBM (4-30%) (p 
< 0.01). δ = significantly larger value compared to PHA-DBM (4-20%) (p < 0.05). 
µ = significantly larger value compared to PHA-DVT (4-10%) (p < 0.05). PHA = 
pentanoate-functionalized hyaluronic acid, DBM = demineralized bone matrix, 
DVC = devitalized cartilage, DVM = devitalized meniscus, DVT = devitalized 
tendon. 
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Figure 5.2: Aim 3 Regenerated Bone Volume and µCT Imaging 
Microcomputed tomography (µCT) analysis using Avizo software after 8 weeks 
post hydrogel implantation (n = 5). A) Representative µCT scans of calvarial 
defect groups. Orange coloring indicates the space in which the original defect 
was created. Scale bar = 5 mm. Note greater bone regeneration for PHA hydrogel 
groups. B) Percent regenerated bone volume determined by µCT. α = 
significantly larger value compared to the sham, HA-DVC (4-30%), HA-DVM (4-
30%), HA-DVT (4-30%), PHA-DVC (4-30%), and PHA-DVM (4-30%) (p < 
0.0001). β = significantly larger value compared to the sham, HA-DVM (4-30%), 
and HA-DVT (4-30%) (p < 0.05). γ = significantly larger value compared to DBX® 
(p < 0.01). δ = significantly larger value compared to PHA-DBM (4-30%) (p < 
0.05).   HA = Hyaluronic acid, PHA = pentanoate-functionalized hyaluronic acid, 
DBM = demineralized bone matrix, DVC = devitalized cartilage, DVM = 
devitalized meniscus, DVT = devitalized tendon.  
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Figure 5.3: Aim 3 H&E Staining  
Histological analysis of rat calvarial defects after 8 weeks post implantation (n = 
5). Sections were taken from the sagittal plane in which the dural side of the 
calvaria is the bottom of each image. Sections were stained with hematoxylin and 
eosin (H&E) and magnified images shown below each overall section correlate 
to the box above. Note thicker bone formation in hydrogels containing PHA. Scale 
bar = 1 mm. HA = hyaluronic acid, PHA = pentanoate-functionalized hyaluronic 
acid, DBM = demineralized bone matrix, DVC = devitalized cartilage, DVM = 
devitalized meniscus, DVT = devitalized tendon. 
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Figure 5.4: Aim 3 Biochemical Analysis 
Biochemical analysis of hydrogels for 10 consecutive days of in vitro cell culture 
(n = 5). A) DNA content after 2 and 10 days of cell culture. Note high DNA content 
on PHA-DVT (4-30%) hydrogels after 2 days of culture. α = significantly greater 
DNA content compared to all other day 2 groups (p < 0.0001). ∆ = significantly 
greater increase in DNA content between day 2 and day 10 (p < 0.0001). β = 
significantly larger value compared to all day 10 groups except PHA-DVT (4-30%) 
(p < 0.01). µ = significantly larger value compared to all other day 10 groups 
except the TCP group (p < 0.0001). B) Deposited calcium content after 2 and 10 
days of cell culture. Note increased calcium deposition on DVT hydrogels after 
10 days of cell culture. γ = indicates a near zero result. D = significantly greater 
increase in calcium content between day 2 and day 10 (p < 0.0001). α = 
significantly larger value compared to all day 10 groups excluding those 
containing DVT (p < 0.0001). µ = significantly larger value compared to all day 10 
groups excluding those containing DVT and the PHA-DBM (4-10%) group (p < 
0.05). β = significantly larger value compared to PHA-DBM (4-30%) (p < 0.001). 
PHA = pentanoate-functionalized hyaluronic acid, DBM = demineralized bone 
matrix, DVT = devitalized tendon, TCP = tissue culture plastic. 
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Table 2.1: Summary of Hydrogel Rheological Properties 
Summary of rheological properties of hydrogel precursor solutions. Dash marks (-) = data not provided. 
Reference Hydrogel 
Type 
Materials Methods Shear 
Response 
Recovery 
Time 
Yield 
Stress 
Avery et 
al.(159) 
 
Physical 
Charge 
Gelatin and 
silicate 
nanoplatelets 
25 mm cone 
and plate 
(1°) 
Thinning <1 min - 
Beck et 
al.(51)  
Chemical 
Photoinitiated 
Methacrylated 
hyaluronic acid 
and hyaluronic 
acid nanoparticles 
20 mm 
parallel plate 
Thinning - ~18 to 
160 Pa 
Beck et 
al.(35) 
Chemical 
Photoinitiated 
Methacrylated 
hyaluronic acid 
and hyaluronic 
acid nanoparticles 
20 mm 
parallel 
plate, 500 
µm gap 
Thinning <5 mins ~200 to 
700 Pa 
Beck et 
al.(2) 
Chemical 
Photoinitiated 
Methacrylated 
solubilized 
devitalized 
cartilage and 
devitalized 
cartilage 
microparticles 
20 mm 
parallel 
plate, 500 
µm gap 
Thinning - ~30 to 
1500 Pa 
Beck et 
al.(48)  
Chemical 
Photoinitiated 
Methacrylated 
hyaluronic acid 
and 
devitalized/decell
ularized cartilage 
microparticles 
20 mm 
cross-
hatched 
parallel 
plate, 500 
µm gap 
Thinning - ~90 to 
240 Pa 
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Dennis et 
al.(34) 
Physical 
Colloidal 
Flocculation 
Chondroitin 
sulfate or 
hyaluronic acid 
with 
hydroxyapatite 
nanoparticles 
20 mm 
parallel 
plate, 500 
µm gap 
Thinning <5 mins ~1 to 
1400 Pa 
Dennis et 
al.(57) 
 
Physical 
Colloidal 
Flocculation 
Hyaluronic acid, 
hydroxyapatite 
nanoparticles, 
and micronized 
tissue ECM 
20 mm 
cross-
hatched 
parallel 
plate, 500 
µm gap 
Thinning <5 mins ~100 to 
1000 Pa 
Diba et 
al.(160) 
 
Physical 
Colloidal 
Flocculation 
Bisphosphonate-
functionalized 
hyaluronan and 
bioactive glass 
particles 
8 mm 
parallel plate 
Thinning Immediate ~160 to 
260% 
(Yield 
Strain) 
Dumas et 
al.(64) 
 
Chemical 
Reaction 
Lysine-derived 
polyurethane and 
bone particles 
25 mm 
parallel 
plate, 1000 
µm gap 
Thinning - 2.1 Pa 
Fakhari et 
al.(49) 
 
Physical  
Entanglement 
Hyaluronic acid 
nanoparticles 
20 mm cone 
and plate 
(2°) 
Thinning - ~500 to 
2300 Pa 
Gaharwar 
et al.(59) 
Physical 
Charge 
Gelatin and 
silicate 
nanoplatelets 
Static Tests: 
25 mm 
Parallel 
Plate, 500 
µm gap 
Thinning <10 s 2 to 89 
Pa 
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Transient 
Tests: 25 
mm Cone 
and Plate 
(1°) 
 
Geisler et 
al.(45) 
Physical 
Peptide 
Interactions 
Peptide 
(VKVKVKVKVKV-
NH2) 
25 mm 
parallel 
plate, 500 
nm gap 
Thinning Immediate - 
Glassman 
et al.(46) 
 
Physical 
Peptide 
Interactions 
Protein-polymer 
triblock copolymer  
25 mm 
sandblasted 
cone and 
plate (1°) 
Thinning - ~9 kPa 
Gao et 
al.(62) 
 
Physical 
Hydrophobic 
Interactions 
Pyrene-tailored 
pyridinium and 
2,4,7-
trinitrofluorenone 
 
25 mm 
parallel plate 
- <180 s 78% 
(Yield 
Strain) 
Hao et 
al.(58) 
 
Physical 
Entanglement 
Hydrophobically 
modified 
polyacrylamide 
and sodium 
oleate micelles 
40 mm cone 
and plate 
(1°) 
- <10 s - 
Li et 
al.(161) 
 
Chemical  
Reaction 
Glycol-chitosan 
and 
dibenzaldehyde-
terminated 
polyethylene-
glycol 
20 mm 
parallel plate 
- 40 to 84 min - 
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Liu et 
al.(61) 
 
Physical 
Hydrophobic 
Interactions 
Dexamethosone 
phosphate, 
betamethasone 
phosphate, and 
hydrocortisone 
phosphate 
 
20 mm cone 
and plate 
Thinning <10 s 9.8% 
(Yield 
Strain) 
Lu et 
al.(47) 
Physical 
Peptide 
Interactions 
Peptide-PEG 
copolymer with 
dimerization and 
docking domain 
polypeptide    
20 mm cone 
and plate, 27 
µm gap 
Thinning ~6 s ~100 to 
400% 
(Yield 
Strain) 
Olsen et 
al.(60) 
Physical 
Peptide 
Interactions 
Telechelic 
proteins with 
coiled-coil 
endblocks and 
flexible 
polyelectrolyte 
midblocks 
25 mm cone 
and plate 
Thinning <10 s ~1400 Pa 
Rodell et 
al.(162) 
Physical 
Hydrophobic 
Interactions 
Hyaluronic acid 
functionalized 
with guest 
(adamantine) and 
host (β-
cyclodextrin) 
20 mm cone 
and plate 
(1°) 
Thinning <10 s ~60%  
(Yield 
Strain) 
Rodell et 
al.(163) 
 
Combinational 
Hydrophobic 
Interactions 
and Chemical 
Reaction 
Dual crosslinking 
hyaluronic acid 
functionalized 
with guest 
(adamantine) and 
20 mm cone 
and plate 
Thinning <3 s 35% 
(Yield 
Strain) 
 
 
 
 
1
5
3
 
host (β-
cyclodextrin), and 
thiol/methacrylate 
groups    
Rughani et 
al.(98) 
 
Combinational 
Peptide 
Interactions 
and 
Photoinitiated 
Self-assembling 
β-hairpin peptide 
incorporating non-
natural sorbamide 
residues 
25 mm 
parallel 
plate, 500 
µm gap 
Thinning <2 h - 
Samaniuk 
et al.(67) 
- Mayonnaise 25.4 mm 
diameter, 
150 mm long 
vane 
rheometer 
- - ~200 Pa 
- Play-Doh - - ~3000 Pa 
Townsend 
et al.(164) 
Physical 
Colloidal 
Flocculation 
Hyaluronic acid, 
hydroxyapatite 
nanoparticles, 
and micronized 
tissue ECM 
20 mm 
cross-
hatched 
parallel 
plate, 500 
µm gap 
Thinning - ~100 to 
550 Pa 
Tsaryk et 
al.(50) 
Physical  
Entanglement 
Collagen and 
hyaluronic acid 
semi-
interpenetrating 
network loaded 
with gelatin 
microspheres 
15 mm 
cross-
hatched 
parallel 
plate, 1000 
µm gap 
Thinning - - 
Vulpe et 
al.(165) 
 
Chemical  
Reaction 
Collagen, 
hyaluronan, and 
sericin 
Concentric 
cylinder 
geometry 
Thinning - - 
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Wang et 
al.(26) 
Physical 
Charge 
Cationic and 
anionic gelatin 
nanospheres 
20 mm 
parallel 
plate, 500 
µm gap 
Thinning <1 min - 
Yu et 
al.(63) 
 
Chemical 
Reaction 
Chain-extended 
PEO-PPO-PEO 
multiblock 
copolymer 
40 mm cone 
and plate 
(1°) 
- Immediate 130% 
(Yield 
Strain) 
 
 
